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The Role of CD8 T Cells in the Pathogenesis of Cutaneous Leishmaniasis
Abstract
Cutaneous leishmaniasis is a significant global health concern with more than 350 million people
worldwide at risk of infection. One of the most interesting and confounding aspects of leishmaniasis is
the broad spectrum of disease severity seen in patients. The role of CD8 T cells during leishmaniasis has
been controversial, but is currently thought to entail the production of IFN-&gamma to polarize CD4 T cells
towards a protective Th1 type immune response. However, analysis of CD8 T cells in human lesions does
not demonstrate significant IFN-&gamma production by these cells. Additionally, CD8 T cells taken from
patient lesions are responsive to a number of other pathogens, indicating significant infiltration of
bystander CD8 T cells into the lesions during natural infection. Given this, we hypothesized that a patient's
immunologic history may have a profound effect on the disease progression of Leishmania infection. To
test this we examined the functionality of CD8 T cells, both antigen specific and bystander cells generated
in response to other pathogens, at the site of infection with L. major. We show that CD8 T cells in the skin
adopt a cytotoxic phenotype and express high levels of gzmB but little IFN-&gamma. To evaluate the
potential role of bystander cells in the lesions during L. major infection, we utilized two distinct infection
scenarios: a prior viral or bacterial infection that is cleared before challenge with L. major and a direct
coinfection with a virus at the peak of lesion formation. In both cases, bystander cells exacerbated the
disease course of L. major. In the case of a previous infection, this immunopathology was not associated
with any change in parasite control. Whereas, in the case of direct coinfection the immunopathology was
associated with an increased parasite burden in both the skin and DLN. Strikingly, regardless of the timing
of the heterologous infection, the immunopathology was mediated in a CD8 T cell, NKG2D dependent
manner. This work identifies NKG2D and its ligands as potential therapeutic targets in leishmaniasis and
has broad implications for the potential role of this pathway in other infections where excessive tissue
damage and immunopathology are observed.

Degree Type
Dissertation

Degree Name
Doctor of Philosophy (PhD)

Graduate Group
Immunology

First Advisor
Phillip Scott

Keywords
CD8 T cells, Coinfections, IL-15, LCMV, Leishmania, NKG2D

Subject Categories
Allergy and Immunology | Immunology and Infectious Disease | Medical Immunology

This dissertation is available at ScholarlyCommons: https://repository.upenn.edu/edissertations/1245

THE ROLE OF CD8 T CELLS IN THE PATHOGENESIS OF CUTANEOUS LEISHMANIASIS
Erika J. Crosby
A DISSERTATION
in
Immunology
Presented to the Faculties of the University of Pennsylvania
in
Partial Fulfillment of the Requirements for the
Degree of Doctor of Philosophy
2014

Supervisor of Dissertation
_____________________________
Phillip Scott, Ph.D.
Vice Dean for Research and Academic Resources
Professor of Immunology

Graduate Group Chairperson
_____________________________
Avinash Bhandoola, M.B., B.S., Ph.D.
Professor of Pathology and Laboratory Medicine

Dissertation Committee
Sandra W. Ryeom, Ph.D., Assistant Professor of Cancer Biology
E. John Wherry, Ph.D., Associate Professor of Microbiology
Jan S. Erikson, Ph.D., Professor of Immunology
Yasmine Belkaid, Ph.D., Chief of Mucosal Immunology Section, NIAID

THE ROLE OF CD8 T CELLS IN THE PATHOGENESIS OF CUTANEOUS LEISHMANIASIS
COPYRIGHT
2014
Erika Jean Crosby

This work is licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0
License

To view a copy of this license, visit:
https://creativecommons.org/licenses/by-nc-sa/2.0/

DEDICATION
I would like to dedicate this dissertation to all of the great mentors that have played a
part in getting me to this point in my life, both personally and professionally, especially
Kari Kromko, Dr. Ken Field, and Dr. Phillip Scott.
“Education is not the filling of a pail, but the lighting of a fire.”
-William Butler Yeats

	
  

iii	
  

ACKNOWLEDGMENT
I would like to acknowledge my advisor, Dr. Phillip Scott, for his mentorship and support
during my Ph.D. work. His guidance has been invaluable and I am grateful to him for
pushing me to think more deeply and to always “have a model”. It has been a privilege
to work for him, learn from him, and do science with him. I thank past and present
members of the Scott lab for making it fun to come to work everyday. I would also like to
thank the members of my thesis committee, Sandra Ryeom, John Wherry, Jan Erikson,
and Yasmine Belkaid for their guidance and support of my research over the past 4
years. I am especially grateful to John Wherry for opening his lab to me as I got all my
LCMV experiments off the ground. The Wherry lab members were always welcoming,
supportive, and helpful as I tried to navigate working in another lab space and mouse
facility. I am grateful to be a part of the fantastic group of immunologists at Penn. It is
truly a special place to work, learn, and develop as a scientist. My colleagues in the
Immunology Graduate Group are some of my favorite people and have been an
amazing support network, especially all the members of my thesis group. I look forward
to collaborating with each one of them in the future.
I would also like to thank my family for their support throughout this endeavor. My
husband is supportive and understanding of the crazy hours and commitment that this
job requires, as only a fellow graduate student could be. My parents, while not always
understanding exactly what it is that I do, have been there to listen, laugh, cry, and cheer
me on the whole way. I could not count any of this a success without the support of the
ones that I love.

	
  

iv	
  

ABSTRACT
THE ROLE OF CD8 T CELLS IN THE PATHOGENESIS OF CUTANEOUS LEISHMANIASIS

Erika J. Crosby
Phillip Scott, Ph.D.
Cutaneous leishmaniasis is a significant global health concern with more than 350
million people worldwide at risk of infection. One of the most interesting and
confounding aspects of leishmaniasis is the broad spectrum of disease severity seen in
patients. The role of CD8 T cells during leishmaniasis has been controversial, but is
currently thought to entail the production of IFN-γ to polarize CD4 T cells towards a
protective Th1 type immune response. However, analysis of CD8 T cells in human
lesions does not demonstrate significant IFN-γ production by these cells. Additionally,
CD8 T cells taken from patient lesions are responsive to a number of other pathogens,
indicating significant infiltration of bystander CD8 T cells into the lesions during natural
infection. Given this, we hypothesized that a patient’s immunologic history may have a
profound effect on the disease progression of Leishmania infection. To test this we
examined the functionality of CD8 T cells, both antigen specific and bystander cells
generated in response to other pathogens, at the site of infection with L. major. We
show that CD8 T cells in the skin adopt a cytotoxic phenotype and express high levels of
gzmB but little IFN-γ. To evaluate the potential role of bystander cells in the lesions
during L. major infection, we utilized two distinct infection scenarios: a prior viral or
bacterial infection that is cleared before challenge with L. major and a direct coinfection
with a virus at the peak of lesion formation. In both cases, bystander cells exacerbated
the disease course of L. major. In the case of a previous infection, this
immunopathology was not associated with any change in parasite control. Whereas, in
the case of direct coinfection the immunopathology was associated with an increased
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parasite burden in both the skin and DLN. Strikingly, regardless of the timing of the
heterologous infection, the immunopathology was mediated in a CD8 T cell, NKG2D
dependent manner. This work identifies NKG2D and its ligands as potential therapeutic
targets in leishmaniasis and has broad implications for the potential role of this pathway
in other infections where excessive tissue damage and immunopathology are observed.
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Chapter 1 Introduction
	
  
1.1 Leishmaniasis
Leishmaniasis is a significant neglected tropical disease with more than 350 million
people in 98 countries worldwide at risk of infection. There are an estimated 1.3 million
new infections and 20,000 to 30,000 deaths occurring as the result of Leishmania
infection every year (Alvar et al., 2012; World Health Organization, 2014). It is caused
by infection with one of several different species of the protozoan parasite that are
transmitted through the bite of an infected sandfly. There are three main forms of the
disease: visceral, cutaneous, and mucocutaneous, with cutaneous infection accounting
for the majority of total infections (World Health Organization, 2014). Even though
cutaneous infection is typically not life threatening, healing of cutaneous lesions is still
associated with the development of disfiguring scars on exposed skin surfaces.
Additionally, it is a chronic infection that persists even after overt disease has resolved.
Under conditions of severe malnutrition or immune suppression, reactivation can occur
(Okwor and Uzonna, 2013). Another poorly understood aspect of disease is the diverse
spectrum of clinical severity seen even among patients infected with the same species of
Leishmania. Despite the significant disease burden, there is currently no vaccine
available and treatment options are ineffective and costly, making leishmaniasis an
important area of continued research (Kedzierski, 2010; Romero et al., 2001; Singh and
Sundar, 2012).
As with any vector borne disease, understanding the distribution and biology of the
vector has important implications for understanding the disease. The sandfly has a
lifespan of less than 30 days and can only travel short distances; therefore, endemic
regions are constrained to areas near larval breeding sites (Maroli et al., 2013). Man	
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made environmental changes in the natural habitats of these vectors, the spread of
immunosuppressive conditions in humans, deforestation, the establishment of new
settlements and cities, and the consequences of widespread war and conflict in endemic
regions have all contributed to the recent spread of infections into countries that
historically have not had endemic disease (Antoniou et al., 2013). It has recently been
appreciated that sandflies are not only the vector, but also are directly involved in the
pathogenesis and immune response to Leishmania. Humans and rodents repeatedly
exposed to the bites of uninfected sandflies develop IgG antibodies and cellular
responses against salivary components (Rohousova et al., 2005). However this immune
activation does not appear to be protective against infection, but rather the presence of
sandfly saliva components in an experimental setting increase the infectivity of the
parasites (Rohousova and Volf, 2006). Future studies are aimed at understanding if
there is a role for sandfly saliva in the establishment of protective immunity and if it
should be included in future vaccine strategies.
In addition to humans, rodents and dogs can serve as secondary reservoirs for the
parasite (Maroli et al., 2013). Rodents being a natural host for Leishmania make them
an ideal model system to study infection in the laboratory. In 1973, infection of various
inbred mouse strains revealed differences in the sensitivity of different strains to
Leishmania infection (Kellina, 1973). This observation began a series of studies aimed
at understanding the immunological basis for this predisposition for susceptibility or
resistance to Leishmania infection. Ultimately, it was determined that susceptibility
correlates with the dominance of an IL-4 driven TH2 response whereas an IL-12/IFN-γ
driven TH1 response promotes protection and parasite control (Heinzel et al., 1989;
Heinzel et al., 1993; Mosmann et al., 1986; Nasseri and Modabber, 1979; Scott et al.,
1988; Sypek et al., 1993). More recent work has challenged the simplicity of this model,
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and while the basic paradigm still holds true, we now understand that there is more to
susceptibility and resistance than just the TH1/TH2 dichotomy.
Leishmania parasites have a dimorphic life cycle: extracellular, flagellated promastigotes
divide and mature within the midgut of sandflies and intracellular amastigotes reside and
multiply within mammalian phagocytic cells. Immediately following inoculation into the
skin, parasites are rapidly phagocytosed by resident dermal macrophages and dermal
dendritic cells (DCs) (Locksley et al., 1988; Ng et al., 2008). Neutrophils also rapidly
infiltrate the infected skin and phagocytose promastigotes (Laskay et al., 2003; Peters et
al., 2008). Similar to Mycobacterium or Salmonella, once in the mammalian host,
Leishmania survive inside the phagolysosome of the infected cell. In fact, the acidic
environment present in the phagolysosome is important for the maturation of the
parasite from promastigote to amastigote (Meresse et al., 1999; Russell et al., 1992).
After several asexual divisions, the amastigotes rupture the host cell and are rapidly
taken up by other phagocytes, mainly macrophages (Scott et al., 2004). Control of the
parasite is mediated through activation of infected macrophages by IFN-γ to express
nitric oxide. This requirement for IFN-γ is ultimately why resistance is characterized by a
TH1 type immune response and why examining the source of this IFN-γ has been the
focus of so much work.
CD4 T cells are critically important for the control of Leishmania infections because they
serve as the main source of IFN-γ (Scott, 1991). Mice that are deficient in CD4 T cells,
IL-12p40, IFN-γ, or iNOS all fail to control parasite replication (Belkaid et al., 2000;
Mattner et al., 1996; Swihart et al., 1995). Similarly, mouse strains that would typically
be susceptible to infection can be treated with IL-12, develop a TH1 response, and
become resistant to infection (Heinzel et al., 1993; Sypek et al., 1993). CD4 T cells are
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known to be required not only for control of the primary infection, but are also required
for long lived secondary immunity. Despite this, the establishment and maintenance of
Leishmania-specific CD4 memory cells is not well understood. Previous work has
demonstrated that the maintenance of protective immunity is dependent on low level
persistence of parasite, but central memory CD4 T cells can persist in the absence of
parasite and can provide some level of protection when transferred into naïve hosts
(Belkaid et al., 2002; Scott et al., 2004). However, transfer of central memory CD4 T
cells alone cannot offer the same level of protection as seen in an immune animal,
suggesting that other elements of the immune response or parasite persistence are also
playing a role; this is an area of ongoing investigation in our lab.
1.2 CD8 T cells and Leishmaniasis
While the role of CD4 T cells has long been established, the role of CD8 T cells during
Leishmania infection has been much more controversial. Initial studies suggested that
CD8 T cells were important in control of infection in both susceptible and resistant
strains, demonstrating that depletion of CD8 T cells during infection made lesions larger
and slower to heal (Titus et al., 1987). Similarly, in the susceptible BALB/c strain, if CD4
T cells were depleted, the remaining CD8 T cells were able to control parasite replication
and confer resistance (Hill et al., 1989; Muller et al., 1991). However, later studies ruled
out a role for CD8 T cells during primary infection, showing that CD8 deficient or β2microglobulin deficient mice had no change in the course of Leishmania infection (Huber
et al., 1998; Overath and Harbecke, 1993; Wang et al., 1993). Mice deficient in
granzyme A, granzyme A and B, or perforin, the major cytotoxic granule components,
also had no change in lesion resolution or parasite control (Conceicao-Silva et al., 1998;
Eisert et al., 2002). Despite their dispensability during the primary response, it was
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agreed upon that CD8 T cells were crucial for protective secondary responses through
their production of IFN-γ (Colmenares et al., 2003; Muller et al., 1991; Muller et al.,
1993).
All of these studies examining the role of CD8 T cells had utilized a high dose, footpad
infection. Strikingly, when CD8 deficient mice were challenged with a lower dose,
intradermal infection, they failed to control parasite growth (Belkaid et al., 2002). Further
studies from our lab went on to show that at this lower dose CD8 T cells were a crucial
source of IFN-γ early during infection to establish the protective TH1 CD4 T cell response
(Uzonna et al., 2004). Following infection with both doses, there is a burst of IL-4
production, but this burst is much larger following infection with a low dose of parasite.
IFN-γ production by CD8 T cells was required to down-regulate this IL-4 response
following low dose but not high dose infection. In the low dose model of infection, CD8 T
cells were shown not only to be protective, but also to mediate pathology (Belkaid et al.,
2002). Our lab has recently used a similar model and demonstrated that cytotoxicity,
and not cytokine production, is responsible for the parasite independent pathology
caused by these CD8 T cells (Novais et al., 2013). We also visualized direct killing of
infected cells by CD8 T cells taken from lesions; interestingly in vitro evidence suggests
that killing of an infected cell by a CD8 T cell does not result in the killing of the parasite
(Smith et al., 1991). Together these results underscore an unappreciated role for CD8 T
cells in not only the establishment of protective immunity to Leishmania infection, but
also a potential role in the pathology of the disease as well.
In humans, CD8 T cells have also been shown to participate during Leishmania
infections (Da-Cruz et al., 1994). Analysis of peripheral blood mononuclear cells
(PMBCs) taken from patients with active or healed cutaneous leishmaniasis exhibited
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significant cytotoxicity against L. major infected autologous macrophages (Bousoffara et
al., 2004). Furthermore, cell lysates of parasite stimulated PBMCs from patients with
active infections were analyzed for gzmB activity as a surrogate marker of a cytotoxic
response and 62.5% of them had increased gzmB levels compared to healthy controls
(Bousoffara et al., 2004). Histological analysis of early and late stage lesions from
patients revealed a fivefold increase in the number of CD8 T cells present in late, more
severe lesions compared to smaller, early lesions (Faria et al., 2009). Interestingly, this
analysis further demonstrated an increase in the levels of granzyme A within CD8 T cells
as lesions progressed from early to late, however no significant production of IFN-γ by
CD8 T cells was observed. Similar analysis of lesions was recently completed by a
second group who also concluded that recruitment of granzyme expressing CD8 T cells
was associated with lesion progression and positively correlated with lesion severity
(Dantas et al., 2013; Santos et al., 2013).
Transcriptional analysis of lesional skin revealed that some of the most highly expressed
genes compared to normal skin were components of cytotoxic granules (Novais et al.,
2013). Overall, data from patients confirms a role for CD8 T cells during Leishmania
infection, but seems not to point to cytokine production and protection but rather
cytotoxicity and pathogenicity as their major function. A better understanding of the role
and regulation of CD8 T cells during infection is required for the generation of effective
vaccines or novel therapeutic interventions.
1.3 Coinfections
Disease caused by persistent infections, like Leishmania, impact more than a third of the
world’s population. In addition to posing a significant health risk, chronic infections have
also been shown to impact the ability to appropriately respond to other infections or
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vaccinations (reviewed in Stelekati and Wherry, 2012). In some cases, chronic
infections have been associated with an increased ability to control other infections, but
the vast majority of evidence indicates an increased susceptibility to secondary
infections and a reduced vaccination efficacy. A better understanding of the specific
immunological effects of coinfections is necessary to design targeted therapeutics and
effective vaccines for populations that suffer from chronic infections.
HIV infection represents a significant global health concern, and is complicated further
by the high incidence of coinfections occurring in these immune compromised
individuals. An estimated 4.5 million people are coinfected with HIV and Hepatitis C
virus (HCV). This coinfection is associated with higher HCV persistence, faster
progression of the disease and poor response to current treatments (Lambotin et al.,
2012). Liver disease caused by Hepatitis B virus (HBV) is one of the leading causes of
morbidity and morality in coinfected HIV patients (Iser and Sasadeusz, 2008). In 2010,
an estimated 350,000 deaths were attributed to complications caused by tuberculosis
coinfection in HIV infected individuals (Gray and Cohn, 2013). Together, these data
suggest that a critical factor in preventing or treating global health threats like HIV will be
addressing the complexities of immunological interactions during coinfections.
Another commonly occurring and well-studied coinfection is that of respiratory viruses
and secondary bacterial infections. Autopsy case reports indicate that >90% of deaths
during the 1918 influenza pandemic were likely cause by secondary infection with
pneumococcal bacteria (Morens et al., 2008). Present day, on average approximately
6,000 people die of secondary bacterial infections following influenza in the United
States every year (Centers for Disease Control and Prevention (CDC), 2010).
Historically the mechanisms responsible for the viral/bacterial comorbidity have been
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attributed to virus-induced lung tissue damage. However, the use of mouse models has
more recently implicated a dysfunctional innate immune response for the enhanced
susceptibility (reviewed in Metzger and Sun, 2013). Recent work from Medzhitov’s
group further implicates an impaired ability to tolerate tissue damage rather than failure
to control bacterial infection (Jamieson et al., 2013). Ultimately, this century old
observation of viral induced predisposition to bacterial infection is still not well
understood and is an important ongoing area of research.
As was previously mentioned, Leishmania infection persists chronically, even after
resolution of overt disease. Reactivation of Leishmania infection has become a
significant problem, particularly in patients coinfected with HIV (Okwor and Uzonna,
2013). The first case of Leishmania/HIV coinfection was reported in 1985 and 35
countries have since reported incidences of coinfection (Alvar et al., 2008). Coinfection
of cutaneous leishmaniasis and HIV is associated with an increased rate of leishmanial
recurrence and a decreased responsiveness to therapy (Couppie et al., 2004).
However, HIV is not the only coinfection shown to commonly occur with Leishmania.
Intestinal helminth infection is also highly prevalent in regions that are endemic for
leishmaniasis. Patients coinfected with Leishmania and an intestinal helminth
demonstrated a healing time of nearly twice that of patients without coinfection (O'Neal
et al., 2007). Despite this observation, early anti-helminthic treatment did not improve
the clinical outcome of coinfected patients (Newlove et al., 2011). This highlights the
need for a better basic understanding of how these pathogens, and the immune
responses to these pathogens, impact one another.
Various experimental mouse models have been used to analyze the impact of other
infections on the course of Leishmania disease. Infection with Strongyloides ratti prior to
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infection with L. major had no effect on the disease course or parasite burden of either
parasite (Kolbaum et al., 2011). Alternatively, infection with a different helminth,
Schistosoma mansoni (S. mansoni), prior to infection with L. major led to delayed
resolution of footpad swelling and increased parasite burden, although the L. major
infection was eventually controlled (La Flamme et al., 2002). The increased parasite
burden was attributed to a defect in the production of NO by macrophages from S.
mansoni/ L. major coinfected mice. In contrast, infection with Toxoplasma gondii (T.
gondii) or Listeria monocytogenes prior to infection with L. major protected a susceptible
strain of mice (Santiago et al., 1999; Tabbara et al., 2004). These coinfected mice had
much lower parasite burdens and decreased tissue damage, which were associated with
suppression of IL-4 and increased IFN-γ production in both cases. In summary, there
are experimental examples of coinfections being protective, being pathologic, or having
no effect on the disease course depending on the specific timing and infectious agents
involved. This is likely the case in humans as well, when infectious histories are
complicated and specific to each individual, and we hypothesize that it may be part of
the explanation for the diversity seen in disease severity and duration among patients.
1.4 Heterologous immunity: cross-reactivity versus bystander T cells
One of the hallmarks of adaptive immunity is the establishment of pathogen specific
memory responses that are maintained long term. Although this is a well-accepted
attribute of an immune response, most experimental models studying these immune
responses use pathogen free, ‘naïve’ mice. This is in contrast to humans who are
continuously exposed to different pathogens and have populations of memory cells with
the potential to respond to or cross-react with new infectious agents. The existence of
these memory populations forms the basis for heterologous immunity, or the ability of
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memory cells to respond to and influence the outcome of subsequent, unrelated
infections. There are two main ways that cells are able to do this: bystander activation
or TCR cross-reactivity. Bystander activation occurs when cells respond to inflammatory
signals in an antigen independent manner. TCR cross-reactivity occurs when cells
respond to an epitope that is distinct, yet similar to the epitope for which they were
initially primed. However, the existence and relevance of bystander T cell activation has
long been a topic of debate in the field. Initially because of its magnitude, the massive
expansion of T cells observed during viral infection was thought to be accounted for in
large part by bystander activation. However, tetramer analysis revealed that >80% of
the activated T cells present at the peak of infection are actually antigen specific (Butz
and Bevan, 1998; Masopust et al., 2007; Murali-Krishna et al., 1998; Tough and Sprent,
1998). The concept of bystander T cell activation, independent of specific T cell receptor
(TCR) stimulation, challenges one of the fundamental tenants of the immune responsespecificity. It is widely acknowledged that stringent regulation of every step of the
immune response is required to avoid unnecessary immunopathology, lymphoproliferative disorders, and autoimmunity. Therefore, the activation of a T cell
independent of its TCR seemingly bypasses the intricate regulatory system set up to
protect the host from abhorrent immune activation. Despite the apparent dangers of
bystander activation, many experimental infection models show bystander CD8 T cell
activation as an important mechanism of early protection (Berg et al., 2003; Chu et al.,
2013; Soudja et al., 2012). In light of this, we will discuss what is known about
bystander T cell activation during infection and inflammation, how it differs from TCR
cross-reactivity, and evidence for both scenarios in humans.
Bystander activation can be mediated by inflammatory cytokines. Type I IFNs or IL-12
and IL-18 that are given exogenously, or produced in response to infection or
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inflammation, can induce the proliferation and activation of memory phenotype (CD44hi)
CD8+ T cells (Beadling and Slifka, 2005; Berg et al., 2003; Kamath et al., 2005;
Kambayashi et al., 2003; Raué et al., 2004; Raué et al., 2013; Tough et al., 1996).
Direct injection of IFN-α/β can cause proliferation of memory phenotype CD8 T cells,
even in β-2-microglobulin deficient animals, demonstrating the TCR-independent nature
of this activation (Tough et al., 1996). This activation in response to inflammatory
cytokines is functionally relevant, as bystander CD8 T cells have been shown to provide
increased protection from an unrelated respiratory virus through expression of gzmB in
an IFN-α receptor dependent manner (Kohlmeier et al., 2010). Other work with Listeria
infection demonstrates that type I interferon dependent gzmB induction is modulated
through the secondary production of IL-15 by monocytes (Soudja et al., 2012). In this
model, IFN-γ production by bystander CD8 T cells seemed to be IL-12/18 dependent,
whereas gzmB expression was mediated by IL-15. Additionally, immunotherapeutic
regimens for cancer using high dose IL-2 treatment have provided evidence of antigenindependent, cytokine driven activation of CD8 T cells that can result in significant antitumor effects (Tietze et al., 2012). Some recent in vitro work really demonstrates the
remarkable array of cytokines and cytokine combinations that memory CD8 T cells can
mount distinct responses to, highlighting the complexity and impact of a specific cytokine
milieu (Freeman et al., 2012).
A separate consequence of a heterologous immune response is TCR cross-reactivity.
The notion of specificity in regards to the TCR is a somewhat misleading notion, as each
TCR has the ability to bind many different peptides, albeit with varying affinities (Reiser
et al., 2003). It is also not completely surprising that there is some cross-reactivity
observed within responses, especially those directed at evolutionarily conserved
proteins within groups of viruses or bacteria (Boon et al., 2004; Effros et al., 1977;
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Mongkolsapaya et al., 2003). A cross-reactive TCR response is fundamentally a
different type of immune response than bystander activation that is caused by cytokines;
it signals through different pathways and is characterized by distinct functional
outcomes. An elegant mouse model was recently created that can distinguish signals
through the TCR from activation induced by inflammatory cues; cells receiving a TCR
signal begin to express GFP (Moran et al., 2011). The expression of GFP is strictly
dependent on a TCR stimulus and is directly correlated with the signal strength of the
TCR, making it a powerful tool to distinguish bystander activation from cross-reactivity.
Prior to this, most cross-reactive responses were identified by the observable changes to
the immunodominance hierarchy of the original memory T cell pool. TCR crossreactivity often results in the preferential expansion of a cross-reactive sub-dominant T
cell epitopes, often leading to an alteration in the hierarchy and a narrowing of the
remaining memory T cell responses from the initial infection (Reviewed in Haanen et al.,
1999; Selin et al., 2006). The use of tetramer technology has allowed for some specific
cross-reactive epitopes to be identified; however, most are still not known. Ultimately,
being able to distinguish cross-reactivity from bystander activation will be important
when attempting to modulate these responses therapeutically.
Similar to bystander activation, cross-reactivity can be protective against subsequent
infections. A population of memory CD8 T cells generated by lymphocytic
choriomeningitis virus (LCMV) infection expanded and became activated in response to
infection with vaccinia virus (VV), resulting in significantly enhanced viral clearance and
decreased mortality following an otherwise lethal VV infection (Chen et al., 2001). This
group has further gone on to show the exact cross-reactive epitopes responsible for this
protective immunity (Cornberg et al., 2010). Other studies demonstrate that while crossreactivity can be protective, it can also be pathologic. While previous LCMV infection is
	
  

12	
  

protective against VV, it inhibits the clearance of Respiratory Syncytial Virus (RSV)
(Ostler et al., 2003). Similarly, a history of influenza A (Flu) infection protects against VV
infection, but inhibits clearance of murine cytomegalovirus (MCMV) and LCMV (Chen et
al., 2003). Another major pathological occurrence during a cross-reactive heterologous
immune response is the development of auto- and allo-reactivity. The induction of
autoimmune disease or transplant rejection often occurs during heterologous immune
responses because of molecular mimicry that allows the ‘licensing’ of an autoreactive T
cell response during the inflammatory setting of infection. CD8 T cells that display
allospecific cytotoxic activity have been identified following LCMV, Pichinde virus (PV),
VV, and MCMV infection in mice (Burrows, 1999; Yang, 1989; Strang, 1987; Tomkinson,
1989). Similarly, a mouse model of autoimmune keratitis is induced by herpes simplex
virus-type 1 (HSV-1) infection because T cells specific for the HSV-1 UL6 protein crossreact with a corneal antigen (Zhao et al., 1998). To fully understand the important role
that memory T cells play in balancing the induction of protective immunity versus
immunopathology, the field needs to better understand the interactions between
heterologous immune responses, whether they are cross-reactive, bystander activation,
or more likely a combination of both.
Instances of cross-reactivity and bystander activation have been observed in humans. A
recent longitudinal study was performed to examine the impact of primary Epstein-Barr
virus (EBV) infection on preexisting memory CD8 T cells specific for Flu and
cytomegalovirus (CMV) (Odumade et al., 2012). During natural primary EBV infection,
both flu and CMV specific CD8 T cells became activated and expressed gzmB but
showed no signs of expansion, implicating bystander activation and not cross-reactivity.
In contrast, specific cross-reactive responses have been identified in humans between
flu and HCV (Wedemeyer et al., 2001). Interestingly, analysis of T cell responses
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revealed that patients with an unusually narrow HCV response that included an over
representation of these cross-reactive flu epitopes presented with a severe fulminant,
necrotizing hepatitis (Urbani et al., 2005). Overall, cross-reactivity in humans has been
linked to the induction of immunopathology, not necessarily because it is the most
common manifestation, but because this outcome is easier to measure than increased
resistance to disease. What is increasingly evident is that our understanding of how
immune responses to heterologous pathogens impact one another during natural
infections is severely lacking. As personalized medicine grows in popularity, an
individual’s immunologic history should likely be a critical component of a successful
treatment plan.
1.5 NKG2D and CD8 T cells
NKG2D is an activating receptor that is expressed on all NK cells, most NKT cells and
subpopulations of γδ T cells (Raulet, 2003). In humans, all CD8 T cells also express
NKG2D, but in mice only a subset of activated and memory CD8 T cells do (Diefenbach
et al., 2000; Girardi et al., 2001). NKG2D is a transmembrane C-type lectin-like receptor
that is encoded by the gene KLRK1 (killer cell lectin-like receptor subfamily K member 1)
(Guerra et al., 2008). Unlike other members of the NKG2 family, it forms a homodimer
and has no inhibitory component (Champsaur and Lanier, 2010). In mice, there are two
isoforms of NKG2D that are generated by alternative splicing, a long form (NKG2D-L)
and a short form (NKG2D-S) (Diefenbach et al., 2002). These different isoforms recruit
different adapter proteins; NKG2D-L associates exclusive with DAP10, whereas
NKG2D-S can pair with either DAP10 or DAP12. Humans, however, only express the
long form and therefore can only pair with DAP10 (Rosen et al., 2004). While DAP12
can bind NKG2D-S, deficiency in DAP10 results in complete loss of NKG2D signaling in
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T cells, indicating that it is the crucial adaptor protein, even in mice (Groh et al., 2002;
Karimi et al., 2005).
NKG2D recognizes a family of stress-induced ligands that are MHC class I protein
homologs and new members of this ligand family continue to be discovered in both mice
and humans. The first ligands to be described were MHC class I chain-related protein A
(MICA) and B (MICB) that were expressed in the gastrointestinal epithelium (Groh et al.,
1996). Subsequently another family of ligands that bound the human cytomegalovirus
glycoprotein UL16 (ULBP16) was discovered (Cosman et al., 2001). The orthologs of
these genes in mice were identified as the retinoic acid early inducible cDNA clone-1
(Rae1) and were subsequently shown to also be NKG2D ligands (Nomura et al., 1994;
Zou et al., 1996). Presently there are five known members of the Rae1 family: Rae1α,
Rae1β, Rae1γ, Rae1δ, and Rae1ε, all of which are differentially expressed in different
tissues and mouse strains but are highly homologous to one another (>85% identity).
Another family of NKG2D ligands in mice are Rae1 related proteins, histocompatibility
antigen 60 a (H60a), H60b and H60c (Malarkannan et al., 1998; Takada et al., 2008).
H60c has been shown to be especially highly expressed in the epidermis during wound
repair (Yoshida et al., 2012). The final NKG2D ligand to be discovered in mice is a
murine ULBP-16-like transcript 1 (MULT1), which is highly similar to the human ULBP
proteins (Carayannopoulos et al., 2002). These ligands are upregulated under
conditions of cellular stress, although ligand transcripts and occasionally protein can be
found in normal cells (Takada et al., 2008). There is also experimental evidence that
these ligands can be posttranslationally regulated, making RNA message levels an
unreliable readout of protein expression but allowing the cell to quickly respond to
environmental triggers (Nice et al., 2009). Overall, these ligands act as molecular
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sensors, triggered by infection, DNA damage, and transformation, to activate cells of the
immune system.
While NKG2D expression and function on NK cells has been well described, it was much
more recently that its role on CD8 T cells has been investigated. In mice, it is inducibly
expressed by a subset of activated CD8 T cells. After 5 days of in vitro stimulation of
splenocytes with anti-TCRβ nearly all of the CD8 T cells had upregulated NKG2D,
whereas none of the CD4 T cells had (Ehrlich et al., 2005; Jamieson et al., 2002).
Similarly, the majority of transgenic OTI CD8 T cells that were stimulated with ovalbumin
peptide in vitro had upregulated NKG2D by day 5, but a small population remained
NKG2D negative (Ehrlich et al., 2005; Jamieson et al., 2002). Additionally, following
infection of mice with LCMV, all GP33 tetramer positive cells had expressed NKG2D by
9 days post infection and expression remained high in these cells for at least 8 months
following infection (Jamieson et al., 2002). Another group showed that DUC18
transgenic CD8 T cells (specific for an ERK2 kinase mutant found in many
fibrosarcomas) upregulated NKG2D upon in vitro stimulation, but that after subsequent
rounds of stimulation the expression steadily decreased (Markiewicz et al., 2005).
Despite these reports, not all CD44 positive CD8 T cells in a mouse express NKG2D,
thus the exact requirements for expression and maintenance of NKG2D expression by
CD8 T cells remains an active area of study.
Similar to studies of the expression of NKG2D by CD8 T cells, much of the work on its
exact functional role in CD8 T cells is contradictory and seems to be rather context
dependent. Using a CD8 T cell line that expresses NKG2D or an in vitro activated
transgenic CD8 T cell, it was shown that crosslinking NKG2D alone did not induce a
response, but it did have a costimulatory effect on proliferation, cytotoxicity, IFN-γ
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production and calcium flux similar to CD28 when crosslinking occurred in conjunction
with TCR stimulation (Jamieson et al., 2002; Markiewicz et al., 2005). However, another
study using in vitro activated OTI cells reported that NKG2D did not costimulate in vitro
proliferation or cytotoxicity of these cells (Ehrlich et al., 2005). One interesting difference
seen in vitro between NKG2D and CD28 was that NKG2D engagement with its ligand
could induce the formation of an immune synapse in the absence of cognate antigen
while CD28 did not (Markiewicz et al., 2005). While classically the role of NKG2D on
CD8 T cells is thought to be costimulatory in nature, growing evidence points to a more
NK cell like functioning of this receptor in a TCR independent manner. Using human
CD8 T cells that were subsequently activated in vitro, NKG2D and DAP10 dependent
but MHC class I independent lysis of target cells has been demonstrated (Verneris et al.,
2004). Treatment of mice with a cytokine based anti-CD40/IL-2 cancer immunotherapy
expanded a population of NKG2D expressing memory CD8 T cells that were broadly
cytotoxic against tumor cells (Tietze et al., 2012). Blockade of NKG2D during treatment
resulted in significant decreases in the observed antitumor effects. Strikingly, treatment
of TCR transgenic mice bearing non-antigen expressing tumors still resulted in
significant antitumor cytotoxicity, highlighting the antigen independence of the antitumor
immunity. Overall, in vitro studies have been somewhat inconclusive about the exact
costimulatory function of NKG2D on CD8 T cells and it is likely highly context dependent.
In contrast, both in vitro and in vivo studies have supported a TCR independent role for
NKG2D in cytotoxicity by CD8 T cells. This innate-like functioning of memory CD8 T
cells is a provocative concept, particularly when considered in the context of human
immunity and therapies, and requires additional basic questions to be answered about
its regulation, expression, and function before it can be utilized or manipulated
therapeutically.
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1.6 Summary
Previous studies of CD8 T cells during Leishmania infection have identified a role for
these cells in producing IFN-γ, but patient data seems to indicate that this is not the
whole story. In fact, mounting evidence suggests that CD8 T cells may be responsible
for the severe immunopathology that occurs (Faria et al., 2009; Novais et al., 2013;
Santos et al., 2013). Here we will evaluate the function of both antigen specific and nonantigen specific CD8 T cells in the skin during L. major infection. We know that nonLeishmania specific CD8 T cells are recruited into the lesions of patients, therefore we
will utilize mice that have had previous, unrelated infections to examine the impact of
unrelated memory cells on disease progression (Da-Cruz et al., 2010). The long
disease course and persistent nature of Leishmania infection means that patients are at
high risk for coinfection with other pathogens that likely will impact their immune
response to Leishmania. Given this, we will also employ a model of coinfection
occurring after the establishment of infection with L. major. In both cases we will
examine the expression and function of NKG2D on CD8 T cells, with particular interest
in its role in inducing pathology. The goal of these studies is to develop a better
understanding of the mechanisms that induce immunopathology during leishmaniasis
with the hope of creating effective, more specific treatments in the future.
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Chapter 2 CD8 T cells in Leishmania infected skin have a cytotoxic phenotype
2.1 Abstract
Cutaneous leishmaniasis is a significant global health concern with more than 350
million people in 98 countries worldwide at risk of infection. Despite this significant
disease burden, there are no vaccines available and treatment options are expensive
and ineffective. Mouse models have provided insight into what a protective immune
response to Leishmania infection qualitatively looks like, but have failed to translate this
understanding into new treatments or vaccination strategies. The role of CD8 T cells in
a protective immune response has been controversial, but is currently thought to entail
the production of IFN-γ that is crucial to polarize CD4 T cells towards a protective Th1
type immune response. However, analysis of CD8 T cells in human lesions does not
demonstrate significant IFN-γ production by these cells. Given this, we examined the
functionality of CD8 T cells in the skin at the site of infection with L. major. We show that
while CD8 T cells in the DLN can produce large amounts of IFN-γ, the CD8 T cells in the
skin adopt a cytotoxic phenotype and express high levels of gzmB but little to no IFN-γ.
By utilizing transfer experiments, we further show that gzmB is not only expressed by
antigen specific cells, but is also induced in bystander, non-Leishmania specific CD8 T
cells. This expression of gzmB independent of TCR signals is partially dependent on IL15 production in the lesion. This work highlights an unappreciated function for CD8 T
cells in the skin during Leishmania infection and underscores the impact of inflammatory
signals in the lesion on this function.
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2.2 Introduction
Leishmania is an intracellular protozoan parasite that is transmitted by the bite of an
infected sandfly and causes a diverse clinical spectrum of disease severity (Sacks and
Noben-Trauth, 2002). Cutaneous leishmaniasis can range from subclinical infections, to
self resolving lesions, to chronic disseminated disease (Farah and Malak, 1971; Murray
et al., 2005; Pearson and Sousa, 1996). A mouse model of cutaneous infection has
demonstrated that protective immunity is primarily dependent upon the development of a
strong Th1 CD4 T cell response, which leads to the production of IFN-γ that activates
macrophages to kill the parasites (Kaye and Scott, 2011). It was long questioned
whether CD8 T cells played any role in controlling a primary infection, as some studies
showed no change in parasite burden or disease severity in the absence of CD8 T cells,
while others demonstrated the ability of CD8 T cells to control parasite replication (Hill et
al., 1989; Huber et al., 1998; Muller et al., 1991; Overath and Harbecke, 1993; Titus et
al., 1987; Wang et al., 1993). They were, however, known to be critically important for
protection from a secondary challenge (Colmenares et al., 2003; Muller et al., 1993).
Recently it has been shown that CD8 T cells do play a protective role during primary
infection, but the requirement for the CD8 T cells seems to be dependent on the
infectious dose of parasite used (Belkaid et al., 2002; Uzonna et al., 2004).
Given the critical role for IFN-γ during Leishmania infection, much work has focused on
the ability of CD8 T cells to produce IFN-γ. Several studies have demonstrated that
early production of IFN-γ by CD8 T cells in the DLN is important to shift the immune
response towards a protective Th1 response, particularly at low doses of infection
(Belkaid et al., 2002; Uzonna et al., 2004). A role for cytotoxicity by CD8 T cells seemed
unlikely given that infection of granzyme deficient mice had no effect on parasite burden
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or disease progression (Eisert et al., 2002). Additionally, in vitro experiments
demonstrated that lysis of infected macrophages by CD8 T cells did not result in killing of
the parasites (Smith et al., 1991). However, protective vaccination of mice with a
leishmanial antigen was abrogated in mice deficient in perforin, implicating a role for
cytotoxicity in the protective immunity observed in this system (Colmenares et al., 2003).
Conversely, recent work from our lab has implicated cytotoxicity by CD8 T cells in the
induction of immunopathology and metastasis of parasites without any decrease in
parasite burden (Novais et al., 2013). This pathology was also dependent on perforin
expression by the CD8 T cells. Analysis of peripheral blood mononuclear cells from
patients with active cutaneous leishmaniasis revealed increased granzyme B (gzmB)
activity and significant cytotoxicity against L. major infected autologous macrophages
(Bousoffara et al., 2004). Histological analysis of lesions from patients revealed a fivefold increase in the number of CD8 T cells present in late lesions compared to early
lesions. Interestingly, the CD8 T cells in the late or more severe lesions were
expressing high levels of granzyme whereas most of the IFN-γ being produced in the
lesion was coming from CD4 T cells, not CD8 T cells (Faria et al., 2009; Santos et al.,
2013). Overall the data from patients seems to indicate that our understanding of CD8 T
cell function during Leishmania infection from the mouse model is incomplete and
warrants more careful analysis.
CD8 T cells are often considered to be polyfunctional in that they are able to both act as
cytotoxic cells and produce a variety of inflammatory cytokines, but the heterogeneity of
CD8 T cell responses is highly dependent upon the local inflammatory cytokine milieu
(Berg and Forman, 2006; Freeman et al., 2012; Wirth et al., 2011). Thus, whether CD8 T
cells produce IFN-γ or increase their cytolytic activity is partially dependent on the
cytokines present. For example, the combination of IL-12 and IL-18 promotes IFN-γ
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production by CD8 T cells, while IL-15 or type I IFNs promote increased cytolytic activity
(Beadling and Slifka, 2005; Berg et al., 2003; Berg et al., 2002; Kambayashi et al., 2003;
Kohlmeier et al., 2010; Lertmemongkolchai et al., 2001; Raué et al., 2004; Raué et al.,
2013; Yoshimoto et al., 1998). Increased IFN-γ production by CD8 T cells would be
expected to promote increased resistance to intracellular pathogens like Leishmania that
are known to be sensitive to IFN-γ. In contrast, other cytokines like IL-15, fail to induce
large amounts of IFN-γ, but rather induce an increase in the expression of gzmB (Liu et
al., 2002; Soudja et al., 2012; Yajima et al., 2005). It is therefore important to consider
the inflammatory milieu present within the skin during Leishmania infection to fully
understand the consequences it has on CD8 T cell function, as well as the role cytokine
production by CD8 T cells has on the inflammatory process.
Overall, while much has been done to define the role of CD8 T cells in the DLN during
Leishmania infection, little work has been done to evaluate their role at the site of
infection in the skin. Data from patients indicates that there is a strong correlation
between the severity of the disease and the number of CD8 T cells within the lesions.
Given this, we focused on defining the population of CD8 T cells present in the
leishmanial lesion and evaluating both their functionality and role in disease progression.
We found that CD8 T cells infiltrate into the lesion very early on during infection and
have a cytolytic phenotype while not making much IFN-γ. We went on to show that the
inflammatory environment within the skin during infection drives this CD8 phenotype,
and that gzmB production by CD8 T cells is partially dependent on IL-15 production.
Ultimately it will be important to understand more fully which specific inflammatory
signals are cueing this cytotoxic CD8 phenotype to potentially target them
therapeutically.
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2.3 Materials and methods
Animals
Female C57BL/6 mice and B6-Ly5.2/Cr (CD45.1) (6 weeks old) were purchased from
the National Cancer Institute (Fredericksburg, MD). RAG2/OT-I mice were purchased
from Taconic Farms. Transgenic reporter mice that expressed Thy1.1 under the control
of the IFN-γ promoter were obtained from Casey Weaver and maintained in our animal
colony (Harrington et al., 2008). Animals were housed in a specific pathogen-free
environment and tested negative for pathogens in routine screening. This study was
carried out in strict accordance with the recommendations in the Guide for the Care and
Use of Laboratory Animals of the National Institutes of Health. The protocol was
approved by the Institutional Animal Care and Use Committee, University of
Pennsylvania Animal Welfare Assurance Number A3079-01.
Parasite, virus, and bacterial infections
L. major parasites (Friedlin) or L. major expressing ovalbumin (L. major-OVA) were
grown to the stationary phase in Schneider's Drosophila medium (Gibco) supplemented
with 20% heat-inactivated FBS (Gibco) and 2 mM L-glutamine (Sigma) at 26°C (Prickett
et al., 2006). Metacyclic promastigotes were isolated from 4-5 day old stationary cultures
by density gradients (Späth and Beverley, 2001). Mice were infected with 103 or 2 x 106
metacyclic parasites injected intradermally into the ear. Lesion development was
monitored weekly by taking measurements of ear thickness with digital calipers (Fisher
Scientific). Parasite burden in lesion tissues was assessed using a limiting dilution
assay as previously described (Scott et al., 2004). For viral infections, mice were
infected with 2 x 105 PFU of LCMV Armstrong strain by i.p. injection.
T cell transfers
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For CFSE dilution experiments, CD8 T cells from CD45.1 OTI-RAG mice were isolated
from the spleen and labeled with 2.5 µM CFSE for 5 minutes. The reaction was
quenched with fetal calf serum and 2x104, 2x105, or 2x106 OTI cells were transferred
intravenously into each mouse. Prior to transfer of memory CD8 T cells from LCMV
immune mice, splenocytes were enriched for T cells using the Pan T cell Isolation Kit II
according to the manufacturer’s instructions (Miltenyi Biotec). Enriched fractions were
analyzed by flow cytometry and 3-4 x 106 CD8 T cells were transferred.
Flow cytometry
For flow cytometry, cells were isolated from ears, draining lymph nodes, spleens or
peripheral blood. For ears, dermal sheets were separated and incubated in incomplete
IMDM+GlutaMAX (Gibco) containing 0.25 µg/mL of Liberase TL (Roche, Diagnostics
Corp.) and 10 µg/mL DNase I (Sigma-Aldrich) for 90 minutes at 37°C. Ears, draining
lymph nodes, and spleens were mechanically dissociated by smashing through a 40-µm
cell strainer (Falcon) in PBS containing 0.05% BSA and 20 µM EDTA. Splenocytes
were incubated for <1 minute with ACK lysing buffer (Lonza) to lyse red blood cells.
When indicated, cells were incubated at 4 x 106 cells/ml with Brefeldin A (BFA, 3 µg/ml
final concentration) (eBioscience) alone for 5 hours or with phorbol myristate acetate
(PMA) (Sigma, 100 ng/ml final concentration) and ionomycin (Sigma, 1 µg/ml final
concentration) and BFA for 4-6 hours before staining for flow cytometry. Fixable Aqua
dye (Invitrogen) was added to assess cell viability. Cells were then incubated with FC
block (anti-CD16/32, heat inactivated mouse sera and Rat IgG) followed by
fluorochrome-conjugated antibodies for surface markers CD45, CD45.1, CD45.2, CD8β,
CD4, CD44, and/or CD62L (all eBioscience) and were fixed with 2% paraformaldehyde
(Electron Microscopy Sciences). For intracellular staining, cells were previously
permeabilized with 0.2% of saponin buffer and stained for IFN-γ and/or gzmB
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(eBioscience or Invitrogen). The data were collected using an LSR Fortessa flow
cytometer (BD Bioscience) and analyzed with FlowJo software (Tree Star).
Histopaque
Peripheral blood was collected into a 4% sodium citrate solution. White blood cells were
isolated by underlaying with Histopaque-1083 (Sigma) and spinning for 20 minutes at
400 x g at room temperature.
ELISAs
Supernatants were analyzed using a sandwich ELISA with paired monoclonal antibodies
to detect IFN-γ (eBioscience). Cytokine concentrations were calculated from standard
curves with detection limit of 0.03 ng/mL for IFN-γ. Granzyme B was analyzed by ELISA
using a mouse granzyme B Duoset kit (R&D Systems).
Statistics
Results represent means ± SEM. Data were analyzed using Prism 5.0 (GraphPad
Software, San Diego, CA). Statistical significance was determined using unpaired, onetailed Student's t test with p values given as: *p < 0.05; **p < 0.001; and ***p < 0.0001;
ns p > 0.05. Results with a p value ≤0.05 were considered significant.
2.4 Results
CD8 T cells infiltrate into the skin early after infection with L. major
Given the controversy surrounding the role of CD8 T cells during L. major infection, we
began by examining the T cell infiltration into the infected skin very early, at one week
after infection. We found a striking increase in frequency of CD8 T cells present in L.
major infected ear skin compared to naïve skin, which in specific pathogen free mice has
almost no CD8 T cells (Figure 1A). This represents a greater than 30 fold increase in
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the number of CD8 T cells whereas the CD4 T cell population only increased by 2 fold
(Figure 1B). It is important to note that human skin contains large numbers of T cells, an
important difference to consider when evaluating the recruitment, activation and function
of T cells in this tissue (Clark et al., 2006).
Much work has been done to determine the number of parasites that are deposited in
the skin following the bite of an infected sand fly, and there appears to be a rather
dynamic range from 10 to 105 (Kimblin et al., 2008). It is not known what impact the
number of parasites deposited by the sandfly has on the severity or duration of disease.
This experiment was done using 2x106 metacyclic parasites and the only other careful
characterization of CD8 infiltration into Leishmania infected skin was done using a much
lower infection dose. This group showed that following low dose infection, CD8 T cell
infiltration does not occur until 4-6 weeks and is rather modest in comparison to the CD4
T cells infiltration (Belkaid et al., 2002). Given this difference, we performed a kinetic
analysis of T cell infiltration into the skin during the first 3 weeks to compare recruitment
following low dose or high dose L. major infection. Consistent with previously published
data, there was no observable increase in the percent or number of CD8 T cells in the
first 3 weeks following low dose infection, whereas CD4 T cells began to increase 2
weeks after infection (Figure 1C and 1D). During a high dose challenge, there was a
dramatic increase in the frequency of CD8 T cells in the first week that was maintained
(Figure 1E and 1F). The CD4 T cells increased by a much smaller proportion compared
to CD8 T cells during the first week but continued to increase throughout the first 3
weeks (Figure 1E and 1F). The infiltration of both CD4 and CD8 T cells was much more
robust following high dose infection than low dose infection (Figure 1D and 1F). This is
consistent with the observation that at 21 days post high dose infection there were
visible lesions on the skin, whereas at the same time point following low dose infection
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Figure 1. CD8 T cells are rapidly recruited to the skin following high dose L.
major infection. Mice were infected with L. major or left uninfected and T cell
infiltration into the skin was analyzed (A). The fold increase of CD4 or CD8 T cells in
infected skin over naïve skin was calculated (B). The infiltration of CD4 and CD8 T
cells into the infected skin after low dose (103; C-D) or high dose (2x106; E-F)
infection with L. major was analyzed for the first 21 days. The percent of total cells in
the skin (C and E) or absolute cell numbers (D and F) are shown. Data are
representative of 5 independent experiments (A-B; n=3-5 mice per group) or 2
independent experiments (C-F; n=3-4 mice per group). Data shown in B are pooled
from 5 experiments. Error bars represent the SEM.

there was no visible inflammation. In patients, CD8 T cells have been identified as a
major cell population that is present within the lesions and increased numbers of CD8 T
cells is correlated with increased disease severity (Dantas et al., 2013; Faria et al.,
2009). Although our high dose of infection is still somewhat higher than what might be
expected during natural infection, vaccines have been designed to deliver high doses of
heat killed parasite or parasite antigens, many of which are given intradermally (Noazin
et al., 2008). For these reasons, we chose to use high dose intradermal infection as a
model to study the role of CD8 T cells within leishmanial lesions.
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CD8 T cells in the skin express less IFN-γ than CD4 T cells
Our lab has previously shown a critical role for CD8 T cells to produce IFN-γ in the
draining lymph node (DLN) early following Leishmania infection to help modulate CD4 T
cells responses (Uzonna et al., 2004). In light of this, we examined IFN-γ production by
CD4 and CD8 T cells at 1 week post infection in both the DLN and the infected skin. To
get a sense of how cells were functioning in vivo we stained for IFN-γ after incubation
with BFA alone and no other stimulation (Figure 2A). To measure their potential to make
IFN-γ we also restimulated the cells with PMA/Ionomycin in the presence of BFA (Figure
2D). To better facilitate the comparison between T cells in the skin and DLN, we
pregated on the activation marker CD44 when analyzing T cells in the DLN. With no
restimulation, the only population of cells from the DLN or skin that were making
detectable IFN-γ was CD4 T cells from the infected skin (Figure 2A-2C). When cells
from the DLN were restimulated with PMA/Ionomycin, a population of both CD4 and
CD8 T cells made IFN-γ, but CD8 T cells made significantly more than CD4 T cells
(Figure 2D-2F). This is consistent with the previously demonstrated role for CD8 T cell
derived IFN-γ in the DLN early after infection (Uzonna et al., 2004). In contrast, while
both CD4 and CD8 T cells taken from the skin also made IFN-γ after restimulation, CD4
T cells made significantly more than CD8 T cells (Figure 2D). This was true by both
percentage of CD4+ IFN-γ producers as well as on a per cell basis as reflected by the
fluorescence intensity of IFN-γ (Figure 2E and 2F).
To further analyze IFN-γ production by these populations, we utilized an IFN-γ reporter
mouse that expresses Thy1.1 on the surface of cells that are expressing IFN-γ
(Harrington et al., 2008). The level of Thy1.1 protein on the surface of cells directly
correlates with IFN-γ message levels. This allows us to detect cells that are actively
transcribing IFN-γ without restimulation or intracellular staining. The Thy1.1 reporter
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Figure 2. CD8 T cells in L. major infected skin express gzmB but not IFN-γ. B6
mice were infected with L. major and 1 week post infection the DLN and infected skin
were harvested and incubated with BFA alone (A-C) or restimulated with PMA/
Ionomycin (D-F) and analyzed for IFN-γ production by flow cytometry. T cells in the
DLN were pregated on CD44hi. The percent (B and E) and MFI (C and F) of IFN-γ
producing cells in the skin and DLN were calculated. Thy1.1 reporter mice were
infected with L. major and 5 weeks post infection the infected skin was harvested
and analyzed by flow cytometry (G). Plots were pregated on T cells. The MFI of
Thy1.1 expression was calculated (H). B6 mice were infected with L. major and after
1 week the DLN and infected skin were harvested and incubated with BFA alone (I-J)
and analyzed for gzmB production by flow cytometry. The MFI of gzmB expression
was calculated (J). Data are representative of 3 independent experiments (A-C; D-F;
I-J; n=3-5 mice per group) or 2 independent experiments (G-H; n=3-5 mice per
group). Error bars represent the SEM.

mice were infected with L. major and at the peak of lesion formation, 5 weeks post
infection, cells from the skin were analyzed directly ex vivo for Thy1.1 expression.
Strikingly, significantly more CD4 T cells from the skin were expressing Thy1.1 than CD8
T cells (Figure 2G). The difference in expression levels of Thy1.1 between CD4 and
CD8 T cells was also noteworthy, with CD4 T cells expressing much higher levels than
CD8 T cells (Figure 2H). These results further highlight that CD8 T cells in the skin do
not appear to be producing large amounts of IFN-γ; rather CD4 T cells are the main IFNγ producers in the skin.
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CD8 T cells in the skin are expressing gzmB
In addition to cytokine production, CD8 T cells could also function as cytotoxic cells
during infection. To determine if the CD8 T cells in the skin had a cytotoxic phenotype,
we examined and compared the expression of gzmB, one of the important cytolytic
proteins, in CD8 T cells from the DLN and L. major infected skin. Interestingly, CD8 T
cells from the DLN were negative for gzmB expression, but the majority of CD8 T cells in
the skin were expressing gzmB (Figure 2I and 2J). The expression is shown for cells
incubated with BFA alone, as restimulation with PMA/Ionomycin did not significantly
change the gzmB expression in either the DLN or the skin (data not shown). This data is
consistent with analysis of CD8 T cells from patient lesions, where granzyme expressing
CD8 T cells are a prominent cell population that is associated with increased
inflammatory infiltration and disease severity (Faria et al., 2009; Novais et al., 2013;
Santos et al., 2013).

Leishmania specific cells in the skin express gzmB but not IFN-γ
Having examined the expression of IFN-γ and gzmB by the total CD8 T cell population in
the DLN and skin, we wanted to see if the expression patterns would be similar in a
Leishmania specific CD8 T cell. To do this, we utilized transgenic CD8 T cells that
express a T cell receptor that is specific for ovalbumin, OTI T cells, and a strain of L.
major that expresses ovalbumin (L. major-OVA) (Prickett et al., 2006). Various numbers
of CFSE labeled OTI T cells were transferred into mice and the next day the mice were
infected with L. major or L. major-OVA. After one week, OTI cells in the DLN were
analyzed for dilution of CFSE as a marker for proliferation. As expected, the number of
OTI T cells transferred had a large impact on the amount of division that had occurred
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Figure 3. Antigen specific CD8 T cells in L. major infected skin express gzmB
but not IFN-γ. Transgenic OTI CD8 T cells were isolated from the spleen and labeled
with CFSE. Various numbers of OTI cells were transferred into B6 mice, which were
infected the following day with L. major or L. major-OVA. After 1 week, the DLN were
harvested and the OTI cells were analyzed for CFSE dilution (A). Cells from the DLN
and infected skin were also incubated with BFA alone (B-D) or restimulated with PMA/
Ionomycin (E-G) and analyzed for IFN-γ and gzmB expression by flow cytometry.
The percent (C and F) and MFI (D and G) of IFN-γ or gzmB producing cells in the skin
and DLN were calculated. Data are representative of 3 independent experiments (AD; n=3-4 mice per group) or 2 independent experiments (E-G; n=5 mice per group).
Error bars represent the SEM.

during the first week (Badovinac et al., 2007; Foulds and Shen, 2006). When a small
number of OTI cells (2x104) were transferred >95% of the cells had divided at least 7
times and diluted out their CFSE (Figure 3A). OTI T cells transferred into mice that were
infected with WT L. major did not divide (Figure 3A). Analysis of fully divided (CFSEdim)
CD8 T cells in the DLN without restimulation showed very little expression of IFN-γ or
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gzmB (Figure 3B-3D). However, upon restimulation with PMA/Ionomycin nearly all of
these OTI cells in the DLN made IFN-γ (Figure 3E and 3F). As before, restimulation did
not change the gzmB expression. Interestingly, OTI cells from the skin were all
expressing gzmB and even after restimulation with PMA/Ionomycin did not make much
IFN-γ (Figure 3B-3E). It is especially striking to notice that OTI cells in the DLN were not
expressing gzmB, whereas OTI cells that had similarly diluted their CFSE in the skin
were almost all gzmB+. In contrast, while OTI cells in the DLN could make IFN-γ upon
stimulation, significantly fewer of the OTI cells in the skin produced IFN-γ. Given these
results, we hypothesized that the environment within the leishmanial lesion was altering
the phenotype and function of CD8 T cells such that they became poor cytokine
producers and instead adopted a cytotoxic phenotype.
Non-specific CD8 T cells enter the lesion and express gzmB
CD8 T cells can be recruited to tissues from the blood independent of antigen specificity,
which allows us to test whether the phenotype of CD8 T cells within the leishmanial
lesion was dependent on antigen (Ely et al., 2003). However, it has been shown that the
ability to enter uninflamed tissue occurs during a small window of time early after the
initial activation of a CD8 T cell; therefore, we began by testing the ability of nonLeishmania specific cells of different activation states to traffic to the leishmanial lesion
(Masopust et al., 2004). To ensure that the cells were not specific for Leishmania, we
performed a transfer experiment using transgenic P14 CD8 T cells. These cells express
a TCR specific for the LCMV peptide GP33. P14 T cells were transferred into CD45
congenic C57BL/6 (B6) mice, which were then infected with lymphocytic
choriomeningitis virus (LCMV). The P14 T cells were harvested during the effector
phase (day 5 post-infection) or memory phase (day 30 post-infection) of LCMV infection.
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Naive, effector, or memory P14 T cells were then transferred into three different groups
of congenic mice that had been infected with L. major for 2 weeks (Figure 4A). The
spleen, infected skin, and uninfected control skin were analyzed for the presence of the
donor cells 36 hours later. P14 T cells were readily detected in the spleen at similar
frequencies in each group (Figure 4B and 4E). As predicted based on previous literature
(Butcher and Picker, 1996; Masopust et al., 2004), naïve P14 T cells were unable to
migrate into L. major infected skin (Figure 4C). Similarly, regardless of the activation
state of the transferred cells, none were detected in the uninfected control skin (Figure
4D and 4E). However, both effector and memory P14 T cells were found in the L. major
infected skin (Figure 4C and 4E).
Given that both the effector and memory P14 T cells were able to migrate into the
inflamed skin, we wanted to evaluate their expression of IFN-γ and gzmB. Cells were
harvested and incubated with BFA without additional stimulation. As expected, a large
percentage of effector P14 cells in the spleen expressed gzmB, whereas naïve and
memory P14 T cells did not (Figure 4F and 4H). P14 cells from all three groups were
negative for IFN-γ in the spleen (Figure 4F and 4H). In contrast, both effector and
memory P14 T cells in the infected ear expressed gzmB and IFN-γ, although the IFN-γ
levels were quite low (Figure 4G and 4H). These data suggest that both effector and
memory T cells not only migrate into Leishmania lesions, but also become activated
upon entering the inflamed tissue. It also provides further evidence that CD8 T cells in
the skin during Leishmania infection, regardless of antigen specificity, preferentially
express gzmB over IFN-γ.
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Figure 4. LCMV memory T cells migrate to leishmanial lesions and upregulate gzmB
expression. B6 mice received CD45.1+ P14 cells (P14 chimeras) and were infected with
LCMV for 5 days (effectors) or 30 days (memory). At the indicated time post LCMV infection,
splenocytes were harvested from naïve P14 mice or P14 chimeras and the numbers of P14
CD8 T cells were quantified. Equal numbers (5x105) of P14 CD8 T cells were transferred into
congenically marked B6 mice that had been infected with L. major for 2 weeks (A). After 36
hours, spleens (B), infected ears (C), and contralateral uninfected ears (D) were harvested
from the recipients and P14 frequency was analyzed by flow cytometry (E). P14 CD8 T cells
present in the spleen (F) or infected ear (G) were incubated with BFA alone for 5 hours and
analyzed for production of gzmB and IFN-γ. The relative MFI for each was calculated (H).
Data are representative of two independent experiments (n=3-5 mice/ group). Error bars
represent the SEM.
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Cytokine signals responsible for IFN-γ or gzmB expression by CD8 T cells
In addition to responding to specific antigens, effector and memory phenotype CD8 T
cells can be activated by the cytokine milieu present during inflammation (Freeman et
al., 2012). There is much evidence for the role of cytokines in the functional
programming of CD8 T cells both in vitro and during various types of infections. One of
the most potent and well-studied combinations of cytokines that induce IFN-γ production
is IL-12 and IL-18 (Berg et al., 2003; Bou Ghanem et al., 2010; Freeman et al., 2012;
Kambayashi et al., 2003; Raué et al., 2004; Raué et al., 2013). Less is known about the
effect of the cytokine environment on gzmB expression. We wanted to examine the
ability of activated CD8 T cells in L. major infected mice to respond to various cytokines
in order to see if there was a cytokine signal that would differentially regulate IFN-γ and
gzmB expression within CD8 T cells similarly to what we saw in the skin during L. major
infection. We incubated splenocytes with cytokines for 36 hours, added BFA to the
cultures for the final 6 hours of the incubation, and measured the production of IFN-γ or
gzmB by staining the cells for flow cytometry (Figure 5A and 5C) or analyzing the culture
supernatants (Figure 5B and 5D). As expected, the combination of IL-12 and IL-18
induced large amounts of IFN-γ production by CD8 T cells as well as a moderate
amount of gzmB (Figure 5A and 5B). The combination of IL-2 and IL-18 also had a
synergistic effect on gzmB production, inducing over half of the CD44hi CD8 T cells in
the culture to express gzmB (Figure 5C). Interestingly, while IL-15 treatment did not
induce any IFN-γ production, it had a potent effect on gzmB expression (Figure 5C and
5D). This is consistent with findings that IL-15 can enhance the cytolytic activity of
memory CD8 T cells during Listeria infection (Soudja et al., 2012).
Having identified IL-12 + IL-18 and IL-15 as potential IFN-γ and gzmB inducers
respectively, we repeated these in vitro stimulations to further interrogate the effect of
	
  

35	
  

these cytokines on the IFN-γ and gzmB production by CD8 T cells from mice with
different immunological histories. Despite using CD44 as a marker for activation, we
predicted that CD44hi CD8 T cells from a naïve mouse would respond to cytokines
differently than those from a mouse with an active infection or one with infection induced
memory cells. To test this, we incubated splenocytes from naïve, L. major infected (4
weeks post infection), or lymphocytic choriomeningitis virus (LCMV) immune (4 weeks
post infection with acute strain) mice with cytokines for 12 (Figure 5E) or 36 (Figure 5F)
hours and examined the expression of IFN-γ or gzmB by CD44hi CD8 T cells in each
group. After only 12 hours, we again observed that IL-12 + IL-18 induced IFN-γ but very
little gzmB expression while IL-15 had the exact opposite effect (Figure 5E). CD8
memory T cells from LCMV immune mice were better able to respond to IL-12 + IL-18 at
this early time point than cells from naïve or L. major infected mice, as evidenced by
increased expression of IFN-γ (Figure 5E). This is consistent with the observation that
cytokine gene expression remains high in memory cells, allowing for rapid production of
cytokines upon reactivation (DiSpirito and Shen, 2010; Kaech et al., 2002). At 36 hours,
as we saw before, IL-12 + IL-18 induced high amounts of IFN-γ and also induced some
expression of gzmB (Figure 5F). Strikingly, while prolonged exposure to IL-15
dramatically increased the amount of gzmB expression by CD8 T cells in all 3 groups of
mice, none of these cells expressed IFN-γ (Figure 5F). Taken together these data
provide evidence that differently activated CD44hi CD8 T cells can respond to cytokine
signals uniquely and that IL-15 is a potential candidate for a signal that induces gzmB
expression but not IFN-γ in the skin during L. major infection.
IL-15 is expressed in the skin
IL-15 is a unique cytokine in that it is thought to be trans-presented on the surface of
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Figure 5. IL-15 induces gzmB expression but not IFN-γ. B6 mice were infected
with L. major and 4 weeks after infection, splenocytes were harvested, and cells were
cultured with various cytokines or media alone for 36 hours. BFA was added for the
final 6 hours of culture. Supernatants were removed for analysis by ELISA (B and D)
and cells were analyzed for IFN-γ and gzmB expression by flow cytometry (A and C).
B6 mice were infected with LCMV or L. major for 4 weeks or left uninfected,
splenocytes were harvested, and cells were cultured with IL-12 + IL-18 or IL-15 for 12
hours (E) or 36 hours (F). BFA was added for the final 6 hours of culture. Cells were
gated on CD44hi CD8+ T cells and analyzed for IFN-γ and gzmB expression by flow
cytometry and MFI for each was calculated (E and F). Data are representative of 2
independent experiments (A-D; n=3 mice/group) or 3 independent experiments (E-F;
n=5 mice/group). Error bars represent the SEM.
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cells by binding the high affinity subunit of its receptor, IL-15Rα (Stonier and Schluns,
2010). This unique feature allows the surface expression of IL-15Rα to be used as a
marker for cells that could trans-present IL-15. Using targeted expression of IL-15Rα, it
has been shown that dendritic cells (DCs) are an important source of IL-15 transpresentation to CD8 T cells (Stonier and Schluns, 2010). We therefore examined DCs in
the skin for expression of IL-15Rα to determine if IL-15 could be playing a role during
infection. DCs from both naïve and L. major infected skin express fairly high levels of IL15Rα (Figure 6A). The expression levels on DCs in L. major infected skin are lower as
assessed by MFI, however it is important to remember that the numbers of DCs in
infected skin compared to naïve skin are much higher, resulting in an overall increase in
the number of IL-15Rα expressing cells following infection.

IL-15 is required for the early expression of gzmB
To test whether IL-15 is playing a role in the gzmB expression by CD8 T cells in the skin
during L. major infection, we once again used a transfer system. To minimize the impact
of TCR driven expression of gzmB, we transferred CD8 T cells from LCMV immune mice
into mice that were infected with L. major (Figure 6B). While these cells were not
transgenic, the majority of activated cells in these mice are LCMV specific and LCMV
has been shown to have no detectable cross reactivity with L. major (Chapter 3). To test
the role of IL-15 on expression of gzmB in the skin, cells were transferred into WT or IL15KO mice. Prior to transfer, resting LCMV memory cells were not expressing gzmB
(Figure 6C). After 36 hours, a population of transferred cells was detectable in the L.
major infected skin. Over half of the LCMV memory CD8 T cells from the WT mouse
were expressing gzmB, while significantly fewer of the cells transferred into the IL-15KO
mice were (Figure 6D). This decrease was seen not only in the percent of cells
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Figure 6. IL-15 is required for the early induction of gzmB in L. major infected
skin. B6 mice were infected with L. major and 1 week post infection the skin was
harvested and analyzed by flow cytometry (A). Plot was pregated on live, CD45+,
CD11c+ cells. B6 mice were infected with LCMV and 30 days post infection
splenocytes from LCMV immune mice were harvested and transferred into WT or
IL-15KO L. major infected mice (B). GzmB expression was assessed on cells prior to
transfer (C). After 36 hours (D-E) or 8 days (F-G), infected ears were harvested,
incubated with BFA, and gzmB expression by transferred cells was analyzed by flow
cytometry. The percent of gzmB+ cells and MFI of gzmB expression were calculated
(E and G). Data are representative of 1 experiment (n=5 mice/group). Error bars
represent the SEM.

expressing gzmB, but also in the MFI of gzmB expression (Figure 6E). However, if the
cells were examined 8 days post transfer, the expression of gzmB was the same
whether IL-15 was present in the recipient or not (Figure 6F and 6G). This suggests that
IL-15 is playing a role in the early activation of CD8 T cells in the skin to express gzmB,
but that over time other signals are able to compensate such that, even in the absence
of IL-15, gzmB expression is induced.
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2.5 Discussion
CD8 T cells have been demonstrated to play an important role producing IFN-γ in the
DLN following L. major infection, but little was known about their function in the skin
(Uzonna et al., 2004). As a barrier surface, the skin is an important immunological niche
and is the site of many other types of infections and autoimmune disorders (Gebhardt et
al., 2011; Gudjonsson et al., 2004; Harris et al., 2012; Hijnen et al., 2013; Mackay et al.,
2012). Not surprisingly, analysis of normal human skin revealed that there are ~1x106 T
cells per cm2 of skin, presumably acting as a first line of defense against pathogens
(Clark et al., 2006). We can also detect a significant population of both CD4 and CD8 T
cells in normal human skin samples (unpublished data). Despite this, in naïve mice CD8
T cells are virtually absent from uninflamed skin (Figure 1A). This discrepancy between
human and mouse skin has important implications as we use this model to study
immune responses in the skin.
Here we have shown that CD8 T cells are recruited to the skin very early following
infection with L. major. Contrary to our predictions, these CD8 T cells do not appear to
be making much IFN-γ in the skin, but rather are expressing the cytotoxic protein gzmB.
This phenotype was true of total CD8 T cells present in lesions, antigen specific
transgenic CD8 T cells, and non-specific bystander CD8 T cells that were recruited to
the site of inflammation (Figures 2-4). The production of gzmB rather than IFN-γ by CD8
T cells was especially surprising given that killing of infected cells by CD8 T cells has
been shown to not impact the viability of parasites within those cells, suggesting that
CD8 mediated killing provides no protective advantage for the host (Smith et al., 1991).
Recent work from our lab demonstrated that disease progression and metastasis during
Leishmania braziliensis infection was independent of parasite burden, but rather was
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dependent on CD8 T cells (Novais et al., 2013). Expression of IFN-γ by these cells
played no role in disease severity, however perforin expression was required.
Interestingly, this data is also consistent with analysis of cutaneous lesions from
patients. Granzyme expressing CD8 T cells could be readily found in lesion biopsies
and increased numbers of these cells were correlated with more severe disease (Dantas
et al., 2013; Faria et al., 2009). Together these data demonstrate that CD8 T cells within
Leishmania infected skin adopt a cytotoxic phenotype that promotes immunopathology
and does not control parasite growth.
Our in vitro studies have also examined the responsiveness of differently primed cells to
cytokine stimulation. Despite the use of CD44 broadly as a marker of activation, all cells
that express CD44 are not equal. Use of panel of activation markers and cytokine
receptors would be needed to truly appreciate the heterogeneity of this population.
While we have not exhaustively compared the CD44 expressing populations of CD8 T
cells from a naïve, L. major infected, or LCMV immune mice, we have shown that they
respond with different kinetics to cytokine stimulation (Figure 5). It is interesting to
consider the implications this observation has on the heterogeneity of immune
responses seen in patients, even those infected with the same pathogen. Our prediction
given this data is that the repertoire of naïve, effector, and memory T cells present in
each individual, not just of different specificities but also of different responsiveness to
various inflammatory cytokines, has the potential to significantly impact the overall
magnitude, speed, and effectiveness of their immune response.
Given the detrimental role CD8 T cells appear to be playing in the skin during
Leishmania infection, we wanted to examine the inflammatory signals that might be
responsible for inducing this cytolytic and ultimately pathologic phenotype. Classically,
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CD8 T cells are thought to be both cytotoxic and cytokine producers rather than
exhibiting one function or the other; however, recently high throughput single-cell
analysis of CD8 T cells revealed that most CD8 T cells are actually discordant for these
functions (Varadarajan et al., 2011). Those cells that secreted IFN-γ were not cytotoxic
and vice versa, supporting our data that CD8 T cells in the skin can be cytolytic but not
producing IFN-γ. There is also a tremendous amount of data that demonstrates the
impact that the cytokine milieu has on both the priming of immune responses and the
reactivation of CD8 T cells during subsequent, even unrelated infections (Freeman et al.,
2012; Raué et al., 2013). Our examination of cytokines here revealed IL-15 as a
potential inflammatory signal that could induce gzmB expression without IFN-γ. Transfer
of non-specific CD8 T cells into IL-15KO mice infected with L. major confirmed a role for
IL-15 in the early expression of gzmB but at later time points it was not required for the
expression of gzmB by CD8 T cells in the skin. This data identifies IL-15 as a potential
target for therapeutic manipulation, but also raises additional questions about what other
inflammatory signals might be responsible for the pathologic programming of CD8 T
cells during Leishmania infection. In total, CD8 T cells seem to play a protective role as
cytokine producers in the DLN, but simultaneously act as pathologic cytotoxic cells in the
skin. A better understanding of this dichotomy will be necessary for improved, targeted
therapeutic options and safe, effective vaccine strategies.
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Chapter 3 Engagement of NKG2D on Bystander Memory CD8 T Cells Promotes
Increased Immunopathology Following Leishmania major Infection
3.1 Abstract
One of the hallmarks of adaptive immunity is the development of a long-term pathogen
specific memory response. While persistent memory T cells certainly impact the
immune response during a secondary challenge, their role in unrelated infections is less
clear. To address this issue, we utilized lymphocytic choriomeningitis virus (LCMV) and
Listeria monocytogenes immune mice to investigate whether bystander memory T cells
influence Leishmania major infection. Despite similar parasite burdens, LCMV and
Listeria immune mice exhibited a significant increase in leishmanial lesion size
compared to mice infected with L. major alone. This increased lesion size was due to a
severe inflammatory response, consisting not only of monocytes and neutrophils, but
also significantly more CD8 T cells. Many of the CD8 T cells were LCMV specific and
expressed gzmB and NKG2D, but unexpectedly expressed very little IFN-γ. Moreover, if
CD8 T cells were depleted in LCMV immune mice prior to challenge with L. major, the
increase in lesion size was lost. Strikingly, treating with NKG2D blocking antibodies
abrogated the increased immunopathology observed in LCMV immune mice, showing
that NKG2D engagement on LCMV specific memory CD8 T cells was required for the
observed phenotype. These results indicate that bystander memory CD8 T cells can
participate in an unrelated immune response and induce immunopathology through an
NKG2D dependent mechanism without providing increased protection.
3.2 Introduction
Over time and with increased immunological experience, our pool of memory CD8 T
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cells increases, resulting in a large repertoire of memory T cells that are able to protect
against previously encountered infectious agents. This protection is thought to be life
long and pathogen specific. Less well studied is the ability of these memory T cells to
respond in a TCR-independent fashion that might influence the outcome of an unrelated
infection. A role for bystander memory T cells (i.e. memory T cells that are activated
independent of TCR stimulation) has been described in viral infections, where
subsequent heterologous viral challenge leads to reactivation of memory CD8 T cells
and increased protection (Kohlmeier et al., 2010). Similarly, activation of bystander
memory CD8 T cells has also been observed in bacterial and parasitic infections,
leading to the notion that an accumulation of memory CD8 T cells may promote
increased resistance to unrelated infections (Berg et al., 2003; Chu et al., 2013; Polley et
al., 2005; Soudja et al., 2012). Work from several groups has shown that CD8 T cells
have a remarkable ability to become activated by cytokines in a TCR-independent
manner, characterized by rapid acquisition of effector functions (Freeman et al., 2012;
Marshall et al., 2010; Raué et al., 2004). However, while memory CD8 T cells can
promote increased resistance, in some situations activation of bystander CD8 T cells
may be pathologic and has even been shown to play a role in autoimmune diseases
(Meresse et al., 2004). The inflammatory signals that induce a bystander CD8 T cell to
be protective versus pathologic in different disease states is poorly understood.
Cutaneous leishmaniasis has a wide spectrum of clinical presentations, from mild selfhealing lesions to severe chronic infections. Control of these parasites is primarily
dependent upon the development of a strong CD4 Th1 response, which leads to the
production of IFN-γ that activates macrophages and kills the parasites (Kaye and Scott,
2011; Sacks and Noben-Trauth, 2002). Under some conditions, CD8 T cells also play a
protective role by producing IFN-γ to both directly activate macrophages, and promote
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the development of a strong CD4 Th1 response (Belkaid et al., 2002; Uzonna et al.,
2004). However, disease severity in leishmaniasis is only partially dependent upon the
parasite burden, and some forms of the disease are associated with very few parasites
but an exaggerated immune response (Lessa et al., 2007; Murray et al., 2005; Pearson
and Sousa, 1996). The factors that determine the severity of the disease remain poorly
defined, but may include decreased expression of IL-10 or the IL-10R, thereby leading to
increased production of IFN-γ, TNF-α and/or IL-17 (Bacellar et al., 2009; Boaventura et
al., 2010; Gonzalez-Lombana et al., 2013; Oliveira et al., 2012; Oliveira et al., 2011).
Additionally, in some patients there is a strong correlation between the severity of the
disease and the number of CD8 T cells within the lesions (Brodskyn et al., 1997; Faria et
al., 2009; Santos et al., 2013). Instead of expressing IFN-γ, however, the majority of
these CD8 T cells express gzmB (Faria et al., 2009; Santos et al., 2013). Recently, we
have shown that these cytolytic CD8 T cells promote pathology, rather than resistance
(Novais et al., 2013). Thus, while IFN-γ producing CD8 T cells may be protective in
leishmaniasis, it appears that gzmB expressing CD8 T cells are associated with
enhanced disease.
In this study, we found that bystander CD8 memory T cells exacerbate disease following
infection with L. major. We infected mice with LCMV or Listeria to generate a large pool
of memory CD8 T cells, and challenged the mice with L. major. Following infection with
L. major, LCMV or Listeria immune mice develop significantly larger lesions than control
mice characterized by increased numbers of monocytes, neutrophils, and CD8 T cells
but no change in the parasite burden. Depletion of CD8 T cells following LCMV
infection, but prior to challenge with L. major, resulted in a loss of the observed
pathology. Strikingly, when anti-NKG2D blocking antibodies were given, the increased
immunopathology in LCMV immune mice was completely abrogated, indicating that
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engagement of the NKG2D pathway in CD8 T cells was responsible for the observed
immunopathology. Thus, this work demonstrates that a bystander memory CD8 T cell
population can contribute to the chronic inflammation and immunopathology associated
with cutaneous leishmaniasis.
3.3 Materials and methods
Animals
Female C57BL/6 mice and B6-Ly5.2/Cr (CD45.1) (6 weeks old) were purchased from
the National Cancer Institute (Fredericksburg, MD). RAG2/OT-I mice were purchased
from Taconic Farms. Mice expressing eGFP in all T cells were originally obtained from
Ulrich van Andrian (Harvard University) and crossed with RAG2/OTI mice to generate
GFP+ OTI CD8 T cells. CD45.1+ P14 mice bearing the H-2Db gp33-specific T cell
receptor were maintained in our animal colony (Pircher et al., 1989). Animals were
housed in a specific pathogen-free environment and tested negative for pathogens in
routine screening. This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of Laboratory Animals of the
National Institutes of Health. The protocol was approved by the Institutional Animal Care
and Use Committee, University of Pennsylvania Animal Welfare Assurance Number
A3079-01.
Parasite, virus, and bacterial infections
L. major parasites (Friedlin) or L. major expressing ovalbumin (L. major-OVA) were
grown to the stationary phase in Schneider's Drosophila medium (Gibco) supplemented
with 20% heat-inactivated FBS (Gibco) and 2 mM L-glutamine (Sigma) at 26°C (Prickett
et al., 2006). Metacyclic promastigotes were isolated from 4-5 day old stationary cultures
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by density gradients (Späth and Beverley, 2001). Mice were infected with 2 x 106
metacyclic parasites injected intradermally into the ear. Lesion development was
monitored weekly by taking measurements of ear thickness with digital calipers (Fisher
Scientific). Parasite burden in lesion tissues was assessed using a limiting dilution
assay as previously described (Scott et al., 2004). For viral infections, mice were
infected with 2 x 105 PFU of LCMV Armstrong strain by i.p. injection. For bacterial
infections, mice were prime-boosted with an initial infection of 103 Listeria
monocytogenes expressing ovalbumin (Listeria-OVA) followed 30 days later by an
additional boost infection of 5 x 104 Listeria-OVA, both doses given intravenously.
T cell transfers
P14 chimeras were made by transferring 2 x 104 congenically marked P14 CD8 T cells 1
day prior to infection with LCMV. Prior to transfer of effector or memory P14 CD8 T cells
from P14 chimeras, splenocytes were enriched for T cells using the Pan T cell Isolation
Kit II according to the manufacturer’s instructions (Miltenyi Biotec). Enriched fractions
were analyzed by flow cytometry and 5 x 105 P14 CD8 T cells were transferred. Naïve
P14 CD8 T cells were not enriched prior to transfer. When OTI CD8 T cells were used,
2 x 105 GFP+ cells were transferred 1 day prior to L. major-OVA infection.
Histology
L. major infected ears were taken at the peak of lesion formation, fixed in 10% buffered
formalin, and embedded in paraffin. Longitudinal 5 µm sections were cut and stained
with hematoxylin and eosin or Verhoeff’s stain. For analysis of Rae1-γ, skin was taken
at the peak of lesion formation and frozen in Tissue-Tek OCT compound (Electron
Microscopy Sciences). Longitudinal 5 µm sections were cut and stained with
biotinylated anti-mouse Rae1-γ (eBioscience, CX1). Sections were blocked prior to
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staining with Avidin Biotin blocking solution according to the manufacturer’s instructions
(Thermo Scientific). Photographs were taken with a Nikon Digital Sight DS-Fi1 Color
system, (Nikon eclipse E600 Microscope).
Flow cytometry
For flow cytometry, cells were isolated from ears, draining lymph nodes, spleens or
peripheral blood. For ears, dermal sheets were separated and incubated in incomplete
IMDM+GlutaMAX (Gibco) containing 0.25 µg/mL of Liberase TL (Roche, Diagnostics
Corp.) and 10 µg/mL DNase I (Sigma-Aldrich) for 90 minutes at 37°C. Ears, draining
lymph nodes, and spleens were mechanically dissociated by smashing through a 40-µm
cell strainer (Falcon) in PBS containing 0.05% BSA and 20 µM EDTA. Splenocytes
were incubated for <1 minute with ACK lysing buffer (Lonza) to lyse red blood cells.
When indicated, cells were incubated at 4 x 106 cells/ml with Brefeldin A (BFA, 3 µg/ml
final concentration) (eBioscience) alone for 5 hours, with a pool of 20 LCMV peptides
(each peptide at a final concentration of 0.4 µg/ml) and BFA for 6 hours, or with phorbol
myristate acetate (PMA) (Sigma, 100 ng/ml final concentration) and ionomycin (Sigma, 1
µg/ml final concentration) and BFA for 4-6 hours before staining for flow cytometry. In
experiments analyzing CD107a expression, cells were incubated with BFA, monensin
(eBioscience, 2 µM final concentration), and anti-CD107a (eBioscience) for 6 hours.
Fixable Aqua dye (Invitrogen) was added to assess cell viability. Cells were then
incubated with FC block (anti-CD16/32, heat inactivated mouse sera and Rat IgG)
followed by fluorochrome-conjugated antibodies for surface markers CD45, CD45.1,
CD45.2, CD8β, CD4, CD44, CD62L, CD11b, Ly6C, and/or Ly6G (1A8) (all eBioscience)
and were fixed with 2% paraformaldehyde (Electron Microscopy Sciences). For
intracellular staining, cells were previously permeabilized with 0.2% of saponin buffer
and stained for IFN-γ, gzmB, TNF-α, and/or IL-17A (eBioscience or Invitrogen). The data
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were collected using an LSR Fortessa flow cytometer (BD Bioscience) and analyzed
with FlowJo software (Tree Star). For sorting LCMV memory cells, splenocytes were
stained for surface markers (CD4, CD8β and CD44) and CD8β+ CD44hi cells were sorted
on a FACSAria II (BD Biosciences).
Histopaque
Peripheral blood was collected into a 4% sodium citrate solution. White blood cells were
isolated by underlaying with Histopaque-1083 (Sigma) and spinning for 20 minutes at
400 x g at room temperature.
Ear Homogenization
Whole ears were cut into <1 mm pieces and placed in ice cold PBS with a protease
inhibitor cocktail (Sigma). Samples were homogenized using the FastPrep-24 (MP
Biomedicals) and spun for 20 minutes at 13000 rpm at 4°C in a microcentrifuge. The
supernatants were removed and stored at -80°C until analysis by ELISA as described
below.
Leishmanial antigen restimulation and ELISAs
Leishmanial antigen was obtained from stationary-phase promastigotes of L. major by
resuspending parasites at 1 x 109 parasites/ml in PBS and conducting 20 freeze/thaw
cycles. For measurements of antigen-specific cytokine production, the infected skin
draining retroauricular lymph node was removed, mechanically dissociated, and single
cell suspensions were prepared. Cells were resuspended in complete IMDM+GlutaMAX
(Gibco) supplemented with 10% heat inactivated FBS (Gibco), 2 mM L-glutamine
(Sigma), 100 U of penicillin and 100 µg of streptomycin (Sigma) per mL and 0.05 µM of
β-mercaptoethanol (Sigma). Cells were plated at 4 x 106 cells/mL in 1 ml in 48-well
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plates. Cells were incubated at 37°C in 5% CO2 with 20 x 106 L. major parasites/mL.
Supernatants were collected after 72 hours and stored at -20°C until they were assayed
by sandwich ELISA using paired monoclonal antibody to detect IFN-γ, IL-4 or IL-17
(eBioscience). Cytokine concentrations were calculated from standard curves with
detection limit of 0.03 ng/mL for IFN-γ, 0.015 ng/mL for IL-17A and 7 Units/mL of IL-4.
Granzyme B was analyzed by ELISA using a mouse granzyme B Duoset kit (R&D
Systems).
VITAL assay
A VITAL assay was performed and analyzed as described (Hermans et al., 2004).
Briefly, CD45.1+ CD8 T cells for the VITAL assay were enriched from the lesions of
LCMV immune L. major infected mice at 4 weeks post L. major infection using negative
selection kit for CD8 T cells according to the manufacturer’s instructions (Miltenyi
Biotec). Target cells for this assay were control RMA cells that do not express any
NKG2D ligands or RMA cells that had been stably transfected with Rae1, originally
made by L. Lanier (Cerwenka et al., 2001). RMA control cells were labeled with a high
dose (1 µM) of CTV (Cell trace violet) and Rae1 expressing RMA cells were labeled with
a low dose (0.02 µM) of CTV for use as target cells according to the manufacturer’s
instructions (Life Technologies). Control and Rae1 expressing cells were mixed 1:1 and
incubated with LCMV immune CD8 T cells from the lesion at an effector to target ratio of
4:1 for 5 hours in vitro. The CTV low-to-high ratio of live cells was determined by
analysis on an LSR Fortessa flow cytometer. Dead cells were excluded by propidium
iodide staining. Expression of Rae1 was confirmed using a pan-Rae1 antibody (R&D
systems).
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In vivo antibody treatment
For CD8 depletion, C57BL/6 mice were either infected with LCMV or left uninfected for
45 days. Both groups were then treated with 250 µg anti-CD8 (Clone 53-6.72; BioXCell)
in PBS every 3 days for 15 days for a total of 5 doses. On the final day of antibody
treatment, all groups were infected with L. major as described above. NK1.1 depleting
(500 µg/dose; Clone PK136; BioXCell), NKG2D blocking (200 µg/dose; Clone HMG2D;
BioXCell), and Hamster IgG control (200 µg/dose; BioXCell) antibodies were given 1 day
prior to infection with L. major and twice weekly for the duration of the experiment.
Statistics
Results represent means ± SEM. Data were analyzed using Prism 5.0 (GraphPad
Software, San Diego, CA). Statistical significance was determined using unpaired, onetailed Student's t test with p values given as: *p < 0.05; **p < 0.001; and ***p < 0.0001;
ns p > 0.05. Results with a p value ≤0.05 were considered significant.
3.4 Results
Previous heterologous infection exacerbates the immunopathology of L. major
infection
Having shown previously that LCMV memory T cells readily entered the skin in response
to Leishmania infection (Chapter 2, Figure 4), we wanted to determine if previous
infection with LCMV affected the course of subsequent L. major infection. For this, we
infected B6 mice with LCMV or left them uninfected and waited thirty days for the
infection to clear and a stable memory T cell population to form. All mice were then
infected with L. major and lesion development was monitored over time. Given that
LCMV induces a strong Th1-type immune response, we predicted that the LCMV
immune mice would be more resistant to L. major infection. However, LCMV immune
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mice challenged with L. major had significantly larger lesions than did mice that had
received L. major alone, and the lesions exhibited exacerbated gross pathology (Figure
1A and 1B). In some mice the severe inflammatory response led to permanent loss of
tissue. Despite this increase in lesion size, there were no differences in parasite burden
within the lesions between the two groups at any time point examined (Figure 1E). In
summary, not only were the LCMV immune mice susceptible to infection, the lesions
were larger and more severe than mice that received L. major alone.
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To determine if this was a phenotype specific to LCMV, we did similar experiments with
Listeria monocytogenes. Listeria immune or naïve mice were infected with L. major and
lesion development was monitored. As with the LCMV immune mice, Listeria immune
mice had larger lesions with greater pathology than did control mice, with no
corresponding change in parasite burden (Figure 1C, 1F, and 1G). Taken together,
these unexpected data show that previous heterologous infections can significantly
exacerbate the disease associated with L. major infection, without any increased ability
to control the parasite.
Leishmania-specific cytokine responses are unaffected by previous infection with
LCMV
To determine if a previous LCMV infection impacted the systemic anti-leishmanial
response, cells from the draining lymph node were isolated at various times after L.
major infection from control and LCMV immune mice, and cultured with either media
alone or leishmanial antigen. Supernatants were collected at 72 hours and analyzed for
the presence of IFN-γ, IL-4 or IL-17 by ELISA (Figure 1F). As expected, cells from L.
major infected mice produced significant levels of IFN-γ in response to leishmanial
antigen. Similar levels of IFN-γ were produced in response to stimulation by cells from
LCMV immune L. major infected mice, which is consistent with the fact that there were
no differences in parasite control between mice that had previously been infected with
LCMV and controls. Correspondingly, the levels of IL-4 and IL-17 were quite low in both
groups of mice. When lymph node cells from control naïve or LCMV immune mice were
cultured with leishmanial antigen, very low levels of IFN-γ and no IL-4 or IL-17 were
detected (Figure 1F). Data shown here is from 4 weeks post L. major infection, however
the same results were also seen at earlier (1-2 weeks) and later (8-12 weeks) time
points throughout the infection (data not shown).
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Increased infiltration into the lesions of LCMV immune L. major infected mice
To understand the nature of the increased pathology seen in LCMV immune mice
infected with L. major, we examined the cellular infiltration into the lesions. Staining
leishmanial lesions in control and LCMV immune mice with hematoxylin and eosin
identified an infiltration of leukocytes, predominantly of mononuclear and
polymorphonuclear cells. However, the magnitude of the inflammatory response was
significantly greater in the lesions from LCMV immune mice (Figure 2A). In addition, to
get a better understanding of the structural changes occurring in the lesions from LCMV
immune mice, a Verhoeff’s stain for extracellular matrix proteins was used. These
sections exhibited epidermal thickening (hyperplasia) and spongiosis (Figure 2B),
decreased dermal collagen and increased ulceration (Figure 2C and 2D), as well as
destruction of the ear cartilage (Figure 2C). To further characterize the cellular infiltrate,
we analyzed the cellular composition of the cells in the lesions by flow cytometry. As
expected from the histology, we saw a significant increase in the number of both
monocytes and neutrophils present in the lesions of LCMV immune L. major infected
mice compared to controls (Figure 2E and 2F).
Further analysis by flow cytometry revealed that there was also a significant increase in
the number of CD8 T cells in the lesions of LCMV immune mice (Figure 2G and 2H).
The increase in CD8 T cells was seen as early at 2 weeks post L. major infection and
was maintained throughout the entire course of infection (data not shown). In contrast,
there was no change in the number of CD4 T cells present in the lesion (Figure 2G and
2H). Similar to CD4 T cells, the number of NK and NKT cells was not different in the two
groups (Figure 2I and 2J).
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To determine if the differences in frequencies of T cells in the lesions reflected
differences in the blood, we analyzed T cells circulating in the blood of these animals at
the same time post L. major infection. While a similar frequency and activation profile of
CD4 T cells was observed between the two groups (Figure 3A), there was a significant
increase in the percent of CD8 T cells circulating in the blood of LCMV immune L. major
infected mice relative to control mice. This increase was due to an expansion in the
effector memory population of CD8 T cells (Figure 2B) (Vezys et al., 2009). These
results, taken together with our adoptive transfer experiments (Chapter 2, Figure 4), are
consistent with the idea that LCMV memory CD8 T cells circulating in the blood are
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Figure 3. CD8 T cell population is significantly larger in LCMV immune mice
while CD4 populations remain similar. B6 mice were infected with LCMV or left
uninfected. After 30 days, mice were infected with metacyclic L. major. After 4 weeks,
blood was taken from both groups and white blood cells were isolated. Cells were
stained for surface T cell and activation markers. The proportion of CD4 T cells (A) or
CD8 T cells (B) that were naïve (CD44neg CD62Lhi), central memory (CD44hiCD62Lhi),
or effector memory (CD44hiCD62Llo) was calculated as a frequency of cells in the
lymphocyte gate. Data are representative of four independent experiments (n=5 per
group).

CD8 T cells in leishmanial lesions express gzmB and markers of degranulation
Having seen a significant increase in the number of CD8 T cells within leishmanial
lesions in LCMV immune mice, we next evaluated the function of these CD8 T cells.
Cells were taken from the lesions of either control or LCMV immune mice and incubated
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with BFA for 5 hours. We were particularly interested in examining the production of
IFN-γ and gzmB, two of the major effector proteins of CD8 T cells. CD8 T cells from
either group made little detectable IFN-γ (Figure 4A), and no detectable levels of TNF-α
or IL-17 (data not shown). However, we found that the deficit in IFN-γ production was
overcome if CD8 T cells were stimulated with PMA and ionomycin (data not shown),
indicating that these cells were capable of making IFN-γ, but might not be receiving a
sufficient stimulus to do so in the leishmanial lesions. In contrast to IFN-γ, the majority
of CD8 T cells from the lesion express gzmB (Figure 4A). In addition, there were
significantly more CD8 T cells in the LCMV immune L. major challenged mice
expressing gzmB than in mice that received L. major alone (Figure 4B). CD8 T cells
from the blood at the same time post-infection did not express either of these proteins
(Figure 4C), suggesting that upregulation of gzmB was occurring within the lesion,
although we cannot rule out the possibility that a small number of gzmB expressing CD8
T cells were preferentially recruited to the lesions.
Given the high expression of the cytotoxic protein gzmB, we wanted to assess whether
CD8 T cells from the lesions were actively degranulating. CD107a is expressed in the
cytotoxic granules and will be expressed on the surface of actively degranulating cells.
To assess CD107a expression as a marker for degranulation, we added CD107a
antibody to cultures of cells taken from the lesions that were incubated for 5 hours with
BFA and monensin. There was detectable CD107a expression by CD8 T cells from the
lesions of both control and LCMV immune mice, indicating that these CD8 T cells were
not only expressing gzmB but were also actively degranulating (Figure 4A). As with the
gzmB expression, there were significantly more CD107a expressing CD8 T cells in the
LCMV immune lesions than in mice that had received L. major alone (Figure 4B).
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Figure 4. CD8 T cells infiltrating the leishmanial lesions express gzmB but low
levels of IFN-γ. B6 mice were infected with LCMV Armstrong or left uninfected. After
30 days, mice were infected with L. major. After 4 weeks, infected ears (A) and
peripheral blood (C) were taken for analysis by flow cytometry. Cells from the infected
ears were incubated with BFA, monensin and CD107a antibody for 5 hours and then
stained for additional cell surface markers and intracellular proteins. Representative
dot plots (A) and total cell numbers (B) are shown. Peripheral blood was taken and
white blood cells were isolated and stained for cell surface markers and intracellular
proteins. Representative dot plots are shown (C). Whole ear tissue was homogenized
and supernatants were analyzed for gzmB and IFN-γ by ELISA (D). Flow data are
representative of five independent experiments (n=4-5 mice per group). Ear
supernatant data are representative of two independent experiments (n=4 mice per
group). Percentages are shown as mean ± SEM.

Degranulation by NK cells in the lesions as measured by CD107a expression was not
different in the two groups (data not shown).
The differential production of IFN-γ and gzmB by CD8 T cells was unexpected, and to
directly determine whether the differences we saw by intracellular flow cytometry were
reflected in the actual levels of IFN-γ and gzmB present in the lesions, we homogenized
the lesions and collected the supernatants for analysis by ELISA. Consistent with the
flow cytometry, similar levels of IFN-γ were detected in the lesions of LCMV immune L.
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major infected and control mice (Figure 4D). Given that there were many more CD8 T
cells present in the LCMV immune L. major infected lesions compared with controls, this
result suggests that these CD8 T cells were not producing significant amounts of IFN-γ.
In contrast, there was significantly more gzmB in supernatants from lesions taken from
LCMV immune L. major infected mice compared to controls (Figure 4D). There was no
detectable gzmB in supernatants taken from the skin of naïve mice or LCMV immune
mice. These results support the flow cytometry data indicating that neither group of CD8
T cells make significant amounts of IFN-γ, while gzmB levels are significantly
upregulated in LCMV immune L. major infected skin.
Finally, CD4 T cells from the lesions were also analyzed, and while they exhibited
detectable levels IFN-γ, there were no differences seen between the two groups (data
not shown). This data is consistent with what we saw upon restimulation responses to
leishmanial antigen by draining lymph node cells and homogenized ear supernatants
(Figures 1F and 4D). Given that CD4 T cell derived IFN-γ is crucial for controlling the
parasites, this is also consistent with the data showing that the parasite burden of both
groups were not different (Figure 1E).
LCMV specific CD8 T cells infiltrate leishmanial lesions
Given the increased number of CD8 T cells in the lesions of LCMV immune L. major
infected mice, we hypothesized that this increase was due to an infiltration of LCMV
specific CD8 T cells into the skin. To test this hypothesis we used two different
approaches. First, we utilized a pool of 20 known LCMV peptides to restimulate cells
taken from the infected ear, allowing us to broadly assess the LCMV responsiveness of
the CD8 T cell population in the infected skin. Notably, a significant percentage of the
CD8 T cells in the lesions were LCMV responsive, while there was a negligible response
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Figure 5. LCMV specific CD8 T cells are present in the leishmanial lesion and
express gzmB but low levels of IFN-γ. B6 mice were infected with LCMV Armstrong
or left uninfected. After 30 days, mice were infected with L. major. After 4 weeks, L.
major infected skin was taken and incubated with a pool of 20 LCMV derived
peptides and BFA for 6 hours before staining for surface and intracellular proteins.
Representative plots (A) and pooled data (B) are shown. Data are representative to 2
independent experiments (n=5 per group). P14 T cells were transferred into B6 mice
and the next day a group was infected with LCMV. After 30 days, GFP+ OTI T cells
were transferred into all groups and mice were infected with L. major-OVA (C). After 4
weeks, L. major infected skin was harvested and incubated with BFA for 5 hours.
The samples were analyzed for the presence of P14 cells or OTI cells (D) and
numbers of each were calculated (E). The OTI or P14 cells from the same infected
ear of an LCMV immune L. major infected mouse were also incubated with BFA,
monensin, and CD107a antibody then stained for additional surface and intracellular
proteins (F). Data are representative of four independent experiments (n=4-5 per
group). Percentages are shown as mean ± SEM.

by cells from mice infected with L. major alone (Figure 5A and 5B). This result indicates
that a large proportion of the CD8 T cells that have been recruited to the leishmanial
lesion are LCMV specific. In addition, these results further demonstrate that although
CD8 T cells did not appear to be making IFN-γ within the leishmanial lesions (Figure
4A), when stimulated with LCMV peptides they were capable of producing IFN-γ.
We next used a transgenic T cell transfer system to allow us to directly identify LCMV
specific and L. major specific T cells (Figure 5C). We transferred CD45 congenic P14 T
cells into B6 mice that were subsequently infected with LCMV or left uninfected. After
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thirty days, all mice received GFP+ OTI CD8 T cells (OVA specific) and were challenged
with L. major expressing OVA (L. major-OVA). The course of infection, increased lesion
size in LCMV immune mice, and parasite control were all unchanged by the presence of
these transgenic T cells (Figure 6A and 6B). After L. major-OVA infection, OTI cells
were detectable in the lesions of both groups of mice, although at a relatively low
percentage of the total CD8 T cells (Figure 5D and 5E). This most likely reflects the fact
that many of the CD8 T cells recognize leishmanial antigens other than OVA. Of the
CD8 T cells in the lesions of LCMV immune L. major infected mice, half were P14 cells
(Figure 5D and 5E), once again confirming that a large proportion of the CD8 T cells
present were LCMV specific memory cells. Also, despite L. major-OVA infected mice
receiving the same number of P14 cells as all other groups, there was no detectable
expansion of P14 cells in mice infected with L. major-OVA alone (Figure 5D and 5E).
LCMV specific cells express gzmB and markers of degranulation within
leishmanial lesions
Using the transfer system described above, we found that neither P14 nor OTI cells from
the lesions of LCMV immune L. major infected mice made much IFN-γ, suggesting that
even Leishmania-specific CD8 T cells may be making little IFN-γ in the lesions during a
primary infection (Figure 5F). In contrast, when gzmB expression was evaluated, the
majority of both the OTI and P14 cells were gzmB positive (Figure 5F). Additionally,
when we analyzed CD107a expression, there were detectable CD107a positive P14
cells. While the frequency of CD107a positive OTI and P14 cells was not significantly
different, the number of CD107a positive P14 cells was substantially higher than OTI
cells and included staining that is clearly above background levels (Figure 5F).
Interestingly, in the blood neither IFN-γ nor gzmB were expressed by OTI or P14 cells
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(Figure 6C), consistent with the idea that both antigen specific CD8 T cells and
bystander CD8 T cells are induced to upregulate gzmB within the leishmanial lesions.
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Figure 6. Transfer of P14 CD8 T cells and OTI T cells does not alter lesion
progression or parasite control. P14 cells were transferred into B6 mice and the
next day a group was infected with LCMV. After 30 days, GFP+ OTI cells were
transferred and all mice were infected with L. major-OVA. Ear thickness was
measured weekly (A). Infected skin was taken at various time points post infection
and parasite burden was assessed using a limiting dilution assay (B). After 4 weeks,
blood was taken from both groups and white blood cells were isolated. Cells were
stained for surface and intracellular proteins (C). Data are representative of two
independent experiments (n=4-5 per group). Percentages are shown as mean ±
SEM.

No evidence for cross-reactivity between LCMV and L. major
In some studies, LCMV immune mice that are challenged with heterologous viruses
have been shown to have overlapping or cross-reactive T cell responses (Brehm et al.,
2002; Chen et al., 2012; Cornberg et al., 2010; Nie et al., 2010; Wlodarczyk et al., 2013).
One way to detect these cross-reactive T cell populations is restimulation with LCMV
peptides. Therefore, to test for cross reactivity of LCMV and L. major we stimulated cells
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from the lesions of L. major infected mice with 20 different LCMV peptides. None of the
LCMV peptides induced IFN-γ production in cells from L. major infected mice (Figure 5A
and 5B). Since the hierarchy of immune dominant epitopes can be altered upon
infection with a cross-reactive pathogen (Brehm et al., 2002), we also examined three of
the top immunodominant epitopes for LCMV using tetramer staining. We found no
change in the frequency of the LCMV epitopes in LCMV immune mice following L. major
infection in either the blood or the spleen (Figure 7A and 7B). Moreover, tetramer
staining of the spleen and blood from naïve mice or mice infected with L. major alone
revealed similar frequencies of tetramer positive cells, indicating that L. major infection
alone did not expand these three epitopes (Figure 7A and 7B).
In an alternative approach to look for cross-reactivity, we sorted polyclonal CD44hi CD8
T cells from LCMV immune mice, CFSE labeled them and transferred these cells into
three groups: one that was left naïve, one that was then infected with L. major, and one
that was then infected with LCMV. After 7 days, the transferred LCMV memory cells
were detectable in the spleen and LN of all three groups, but only in the skin of LCMV
infected recipients and not in the L. major infected skin (Figure 7C). Analysis of CFSE
dilution and number of recovered cells revealed that LCMV memory cells transferred into
L. major infected recipients did not proliferate above the background levels seen in naïve
mice (Figure 7D and 7E). As expected, LCMV memory cells transferred into mice that
were subsequently infected with LCMV all proliferated and expanded significantly in
number (Figure 7D and 7E). Finally, since heterologous infections can cause shifts in
the memory repertoire that results in impaired protective responses to rechallenge (Chen
et al., 2012), we tested the ability of LCMV immune mice infected with L. major to handle
the virulent LCMV clone 13 virus, and found that L. major infection had not functionally
altered the ability to mount an effective LCMV immune response (data not shown).
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Figure 7. No evidence for cross-reactivity between LCMV and L. major. B6 mice
were infected with LCMV Armstrong or left uninfected. After 30 days, mice were
infected with L. major. After 4 weeks, blood (A) and spleens (B) were taken for
analysis by flow cytometry and stained with three different tetramers and other
surface markers. B6 mice were infected with LCMV. After 30 days, splenocytes were
harvested and CD44hi CD8 T cells were sorted. Equal numbers of CD44hi CD8 T cells
were CFSE labeled and transferred into mice that were then left uninfected, infected
with L. major, or infected with LCMV. After 1 week, spleens, skin and draining lymph
nodes were harvested and transferred CD45.2+ cells were analyzed by flow
cytometry. Representative plots (C and D) and pooled data (E) are shown. Data are
representative of a single experiment (n=2-3 mice per group).
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Taken together, these experiments indicate that there is no evidence that a crossreactive epitope is responsible for the activation of LCMV-specific CD8 T cells in L.
major lesions.
CD8 T cells required for increased pathology in L. major infected LCMV immune
mice
Given the significant, prolonged infiltration of LCMV specific memory CD8 T cells into
leishmanial lesions, we wanted to determine if the exacerbated immunopathology was
dependent on these CD8 T cells. To test this, we took naïve or LCMV immune mice and
treated them with depleting anti-CD8 antibodies for 2 weeks. Although depletion of
memory CD8 T cells was slightly less effective than that of naïve CD8 T cells, the
treatment significantly decreased the percentage of circulating CD8 T cells in the blood
of LCMV immune mice prior to L. major infection (Figure 8A). We then infected the CD8
depleted and control mice with L. major and monitored the course of infection. Prior to
infection with L. major, we ceased treatment with anti-CD8 antibodies and at 4 weeks
post L. major infection the circulating levels of CD8 T cells in LCMV immune CD8
depleted mice had recovered to levels comparable with L. major infected non-depleted
mice (Figure 8B). Consistent with previous studies, under these conditions CD8
depletion did not influence the course of L. major infection (Huber et al., 1998; Overath
and Harbecke, 1993; Uzonna et al., 2004; Wang et al., 1993) (Figure 8C). As above,
LCMV immune mice when challenged with L. major developed more severe lesions than
control mice (Figure 8C). However, when CD8 depleted LCMV immune mice were
infected with L. major, the lesion size and disease severity was similar to that seen in
mice that had received L. major alone (Figure 8C and 8D). We found that the number of
CD8 T cells in the lesions of LCMV immune CD8 depleted mice was similar to levels
seen in mice that received L. major alone with no CD8 depletion, consistent with our
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ability to reduce the overall CD8 T cell population to normal levels (Figure 8E). In
addition, the number of total cells infiltrating the LCMV immune CD8 depleted lesion was
significantly reduced, reflecting a significant decrease in the number of monocytes and
neutrophils present (data not shown). As observed above with LCMV immune mice,
there was no change in the parasite burden in any of the groups (Figure 8F). Thus,
these data clearly demonstrate that CD8 memory T cells are required for the increased
immunopathology seen in LCMV immune mice.
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CD8 T cells induce immunopathology in an NKG2D dependent manner
Having demonstrated that LCMV memory CD8 T cells are recruited and activated within
leishmanial lesions, and that depletion of these cells abrogates increased disease, we
further examined a mechanism by which the CD8 T cells were inducing
immunopathology. In addition to expressing gzmB, LCMV memory CD8 T cells in
leishmanial lesions of mice appeared to be degranulating, as measured by CD107a
expression. This led us to examine alternate mechanisms for cytotoxicity by CD8 T cells
that might be independent of cognate antigen interactions. A subset of memory CD8 T
cells can express the activating NK cell receptor NKG2D. Engagement of this receptor
can directly kill target cells, independent of TCR signals, through NKG2D recognition, as
well as having a potent costimulatory effect on CD8 T cell activation (Groh et al., 2002;
Jamieson et al., 2002; Meresse et al., 2004; Tietze et al., 2012; Verneris et al., 2004).
There are several families of ligands for NKG2D and these ligands are all stress
induced, MHC class I homologs (Champsaur and Lanier, 2010). We found that CD8 T
cells in the lesions of L. major infected mice expressed low levels of NKG2D, but CD8 T
cells from LCMV immune L. major infected lesions had significantly higher expression of
NKG2D (Figure 9A). This increased expression, combined with the significantly larger
number of total CD8 T cells present in the LCMV immune L. major lesions represents a
substantial increase in the number of NKG2D positive CD8 T cells in these lesions. NK
cells from the lesions of both groups had comparable levels of expression of NKG2D
(data not shown).
Having seen increased expression of NKG2D on CD8 T cells, we next examined the
lesions for expression of NKG2D ligands, specifically a member of the Rae1 family of
ligands, Rae1-γ. Analyzing the skin by flow cytometry revealed expression of Rae1-γ by
CD11b positive cells at a very low level in naïve skin. However, after infection with L.
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major nearly all of the CD11b positive cells present in the lesion were expressing high
levels of Rae1-γ (Figure 9B). Furthermore, analysis of Rae1-γ expression by
immunohistochemistry demonstrated high levels of Rae1-γ within L. major lesions that
are absent in naïve skin (Figure 9C). We observed expression of Rae1-γ both within the
epidermis and widespread throughout the dermal layer of infected skin.
We next wanted to determine if we could link the levels of degranulation by CD8 T cells
from the lesion to NKG2D engagement. To test this, we once again incubated cells from
the lesions with anti-CD107a in the presence or absence of an antibody that blocks the
interaction between NKG2D and its ligands. In the cultures where NKG2D interactions
were blocked, there was significantly less CD107a staining in CD8 T cells from both
groups (Figure 9D). These data indicate that NKG2D interactions contribute to the
degranulation by CD8 T cells from the lesions.
NKG2D engagement can both be costimulatory or induce direct cytotoxicity in CD8 T
cells (Zafirova et al., 2011). To determine whether the NKG2D expressing CD8 T cells
from the lesions of LCMV immune mice were capable of directly lysing NKG2D ligand
expressing cells, we used the VITAL in vitro killing assay (Hermans et al., 2004). Our
target cells were RMA cells that expressed Rae1 or control RMA cells that did not
express any NKG2D ligands (Cerwenka et al., 2001; Chu et al., 2013). We found that
there was significantly more lysis of Rae1 expressing RMA cells than control RMA cells
(Figure 9E). This could also be visualized by the selective loss of live Rae1 expressing
RMA cells compared to control cells (Figure 9F). Taken together, these data suggest
that CD8 T cells from the lesions of LCMV immune mice are capable of killing target
cells in an NKG2D-dependent manner.
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Ultimately we wanted to ascertain whether NKG2D expression by CD8 T cells was
mediating the increased immunopathology observed in LCMV immune mice. We treated
mice with NKG2D-blocking antibody or isotype control antibody starting one day before
infection with L. major and twice a week after infection. We monitored lesion
progression and found that while treatment with NKG2D-blocking antibody had no effect
on the disease course in mice infected with L. major alone, it significantly reduced lesion
size in LCMV immune mice infected with L. major (Figure 9G). As with CD8 depletion,
despite completely reversing the increased immunopathology, there was no effect on
parasite burden in any of the treatment groups (Figure 9H). Given that NKG2D is also
an activating receptor on NK cells, we depleted NK cells during L. major infection and
found that LCMV immune mice still exhibited exacerbated immunopathology (Figure 10).
Taken together, these data demonstrate that LCMV memory CD8 T cells are recruited
into leishmanial lesions, become activated, and induce immunopathology in an NKG2D
dependent manner.
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Figure 10. NK cell are not required for increased immunopathology in LCMV
immune mice. B6 mice were infected with LCMV Armstrong or left uninfected. After
30 days, some mice in each group were treated with NK1.1 depleting antibody or
isotype control antibody. The following day all mice were infected with L. major, and
antibody treatment continued twice weekly for the duration of the experiment.
Infected skin was taken at 6 weeks post infection and depletion of NK cells was
assessed by flow cytometry (A). Ear thickness was measured weekly (B). Infected
skin was taken 6 weeks post infection and parasite burden was assessed using an
LDA (C). Data are representative of a single experiment (n=5 per group).
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3.5 Discussion
This study demonstrates that memory CD8 T cells induced by a previous infection can
enhance the disease severity of a subsequent unrelated infection in the skin. Thus,
challenge of LCMV or Listeria immune mice with L. major resulted in increased lesion
size and exacerbated pathology without any change in parasite control. Analysis of the
leishmanial lesions in LCMV immune mice showed a greater than four-fold increase in
the number of CD8 T cells, at least half of which were LCMV specific. We demonstrated
that LCMV memory T cells can migrate into leishmanial lesions, and because LCMV
immune mice maintained an elevated frequency of activated CD8 T cells circulating in
the blood long after the clearance of virus (Vezys et al., 2009) we believe that the CD8 T
cells in the lesions were from the blood. To test if these CD8 T cells were responsible for
the increased pathology, LCMV immune mice were depleted of CD8 T cells prior to
challenge with L. major and this depletion reversed the increased pathology observed in
LCMV immune mice. Importantly, we further demonstrated that the CD8 T cells were
meditating the increased pathology in an NKG2D dependent manner by blocking these
interactions in vivo. Thus, our results show that bystander memory CD8 T cells can be
recruited non-specifically to the skin during an infection-induced inflammatory response
and instead of increasing protection, can exacerbate disease.
It has become increasingly clear that the study of a single pathogen in mice does not
always reflect “real life” situations, where prevalent coinfections can have a significant
impact on disease. For example, secondary bacterial infections are a common clinical
complication during viral infections in the lung (Beadling and Slifka, 2004; Peltola and
McCullers, 2004). Coinfection-induced changes in the host immune response can
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contribute to disease progression by reducing the ability to control the secondary
pathogen itself or to control pathogen-induced tissue damage (Jamieson et al., 2013;
Jones et al., 1983; Okamoto et al., 2003). In addition to acute coinfections, chronic
infections, such as helminths or mycobacteria, significantly impact the immune
responses to other infections or vaccines (reviewed in Stelekati and Wherry, 2012). In
leishmaniasis, HIV coinfection contributes to enhanced disease, as does simultaneous
infection with schistosomes (Andreani et al., 2012; La Flamme et al., 2002). Taken
together these studies argue that fully understanding the outcome of one infection may
require knowledge about additional ongoing infections. Our study expands this concept
to include the influence of previous infections. Thus, while it is clear that secondary
infections occur and pose a significant health risk, every human has circulating memory
T cells that could potentially impact the disease outcome for future infections. This
makes understanding the role of bystander T cells in disease an important and distinct
question for understanding human disease.
While it has been more than 20 years since bystander T cells were first hypothesized to
participate in immune responses, their relative contribution to the immune response
remains controversial (Ehl et al., 1997; Masopust et al., 2007; Murali-Krishna et al.,
1998; Tough et al., 1996). In the context of viral infections, bystander T cell effects are
often attributed to cross-reactivity and may therefore be TCR-driven (Chen et al., 2001;
Chen et al., 2003; Kim et al., 2002; Selin et al., 1998). While cross-reactive peptides
have been identified for some virus pairs, it is a technically challenging endeavor and in
many cases it is still unclear which epitopes are cross-reactive (Brehm et al., 2002; Chen
et al., 2012; Cornberg et al., 2010; Mathurin et al., 2009; Nie et al., 2010; Welsh et al.,
2004; Wlodarczyk et al., 2013). However, the recent use of TCR transgenic T cells has
provided convincing results that memory CD8 T cells can be activated by inflammatory
	
  

72	
  

cytokines and contribute to immune responses without the need for cognate antigen
stimulation (Berg et al., 2003; Freeman et al., 2012; Kohlmeier et al., 2007; Kohlmeier et
al., 2010; Soudja et al., 2012; Tough et al., 1996). For example, protective immunity to
Listeria can be generated using TCR transgenic memory cells even when the
challenging strain of Listeria does not express the cognate antigen recognized by the
transgenic T cells (Berg et al., 2003; Soudja et al., 2012). IFN-γ production and
proliferation of memory cells are two major readouts that have been used to
demonstrate cross-reactivity (Chen et al., 2001; Kim et al., 2005; Selin et al., 1998;
Wlodarczyk et al., 2013), and LCMV memory cells did not produce IFN-γ in response to
restimulation with leishmanial antigen and did not proliferate in response to infection with
L. major (Figure 1F and 7). Changes in epitope dominance are also an indication that
cross-reactivity is playing role (Brehm et al., 2002), however there was no change in the
dominance hierarchy of major LCMV epitopes following L. major infection and no
expansion of these epitopes was observed in animals infected with L. major alone
(Figure 7A and 7B). Moreover, despite L. major infected animals receiving the same
number of P14 transgenic T cells prior to infection as the LCMV immune group, there
was no expansion or activation of these cells in response to L. major infection alone.
Yet a majority of the P14s present within the lesions of LCMV immune L. major infected
mice were activated and expressing gzmB (Figure 5D and 5E). Additionally, we
observed the same phenotype and activation of CD8 T cells from Listeria immune
animals during L. major infection (Figure 1 and data not shown). Overall, while the
complexity of these pathogens leaves open the possibility of some undetected crossreactivity being involved in the responses we have observed, all of our results are
consistent with activation of bystander CD8 T cells due to the inflammatory milieu
present in the lesion.
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A key difference between many of the previous studies of bystander T cell responses
and our current findings is that instead of increased protection, we find that bystander
memory CD8 T cells have no impact on parasite control, but instead increase pathology.
As most studies have monitored the response of bystander T cells during acute
infections (Berg et al., 2003; Chen et al., 2001; Selin et al., 1998; Soudja et al., 2012), it
is possible that activation of bystander T cells in a chronic, inflammatory environment is
responsible for these differential effects. The sustained recruitment of cells over many
weeks in leishmaniasis may lead to a greater accumulation of bystander CD8 T cells that
can promote pathology. Our study is also the first to characterize the role of bystander
CD8 T cells in the skin, where the pathologic effects of the bystander CD8 T cell
activation can be directly visualized. The most striking difference between our results
and prior studies is that following L. major infection the bystander CD8 T cells recruited
to the skin made gzmB, but little IFN-γ. This is in contrast to other infections where
bystander CD8 T cells were activated and quickly produced IFN-γ, to provide increased
protection (Chen et al., 2001; Chen et al., 2003; Selin et al., 1998; Soudja et al., 2012).
What accounts for this difference in effector function is unclear, however it may be that
the inflammatory response induced by L. major is insufficient to promote IFN-γ
production. Different cytokine environments can differentially regulate the effector profile
of CD8 T cells, with cytokines like IL-12 and IL-18 inducing high amounts of IFN-γ, while
IL-15 induces the upregulation of gzmB (Freeman et al., 2012; Kohlmeier et al., 2010;
Raué et al., 2013; Soudja et al., 2012; Varadarajan et al., 2011). We are currently
examining the role of these cytokines on CD8 T cell activation within leishmanial lesions.
Overall, our work suggests that the nature of the inflammation, including duration,
location, and composition, will impact whether bystander CD8 T cell activation will be
protective or pathologic.
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CD8 T cells have many effector functions that could be playing a role in pathogenicity.
For example, CD8 T cell derived CCL3 and CCL4 increases recruitment and activation
of the inflammatory cells into tissues (Narni-Mancinelli et al., 2007). Production of
chemokines by tissue resident memory CD8 T cells is also important for recruitment of
CD8 T cells to sites of inflammation (Schenkel et al., 2013). Similarly, CD8 T cells
produce inflammatory cytokines, such as IFN-γ, TNF-α, and IL-17 that can promote
tissue destruction (Ortega et al., 2009; Res et al., 2010; Wherry et al., 2003). However,
the levels of these particular cytokines were low or absent in CD8 T cells within the
leishmanial lesions, making them unlikely to be playing a major role (Figures 4 and 5
and data not shown). Additionally, large changes in IFN-γ production would most likely
result in increased parasite killing, which was not observed (Figure 1E). While bystander
CD8 T cells would not be expected to exhibit antigen-specific cytolytic activity, we have
demonstrated that LCMV specific CD8 T cells can act non-specifically through an
NKG2D-dependent mechanism (Figure 9). Recent work has shown that NKG2D
engagement on bystander CD8 memory cells can serve as an innate-like killing
mechanism for early control of bacterial burdens in Listeria infection (Chu et al., 2013).
Here we highlight the pathologic role this pathway can play, leading to excessive cell
death and the induction of enhanced inflammation. These experiments emphasize an
underappreciated effector function of CD8 T cells that can have serious consequences
for disease progression in leishmaniasis, and potentially other diseases as well.
The formation of a protective memory T cell pool is a crucial part of an effective immune
response. However, unlike highly controlled mouse models of disease, humans
encounter many pathogens throughout their life that can increase the size and diversity
of their immunological memory pool. Determining how this pool of memory T cells
impacts future immune responses to unrelated pathogens may be critical for
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understanding the diversity observed in human disease. While differences in each
individual’s response to a given infection is related to pathogen dose and the genetic
and physiological status of the host, our work suggests that the immunological history of
a patient may also play a role. Leishmania infections have a very broad spectrum of
clinical disease ranging from subclinical infection to ulcerating skin lesions to destruction
of the mucosal tissue (Lessa et al., 2007; Murray et al., 2005; Pearson and Sousa,
1996). Both parasite and host factors have been implicated in this diversity, but our
current work indicates that the immunological history of the patient may also directly
impact the severity of leishmanial disease. In support of this idea, non-Leishmania
specific CD8 T cells are found within human leishmanial lesions (Da-Cruz et al., 2010)
and there is a correlation between the number of intralesional CD8 T cells and disease
severity (Faria et al., 2009; Santos et al., 2013). Taken together, our studies
demonstrate that bystander CD8 T cell activation can play a role in leishmanial lesion
progression through the engagement of an NK cell receptor, NKG2D. On a broader
level, our studies highlight the potential importance of heterologous immunological
responses, which remains an under-appreciated aspect of the host immune response to
infection. Understanding how prior immune responses influence subsequent infections
and infection-induced pathology will be important for designing new and effective
therapeutic treatments. This work has identified NKG2D and its ligands as potential
therapeutic targets in leishmaniasis and has broad implications for potential role of this
pathway in other infections where excessive tissue damage and immunopathology are
observed.
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Chapter 4 Coinfection with LCMV exacerbates lesion progression and parasite
control in Leishmania major infected mice in an NKG2D dependent manner

4.1 Abstract
Leishmania is a significant neglected tropical disease that infects 1-2 million people
every year and causes a life long persistent infection. Due to both the chronic nature of
this parasite and its overlapping geographical distribution with many other significant
diseases, including many species of intestinal helminths and HIV, there is a high
incidence of coinfection occurring within patients. Analysis of CD8 T cells isolated from
the lesions of patients revealed that many appear to be specific for pathogens other than
Leishmania. Despite this, little work has been done to evaluate the impact of
coinfections on Leishmania disease progression. Here we show that infection with the
acute virus, lymphocytic choriomeningitis virus (LCMV), during active Leishmania major
(L. major) infection results in significantly increased disease severity and elevated
parasite burden at the peak of infection. Despite this dramatic change in L. major
progression, LCMV was cleared normally. This coinfection resulted in increased
infiltration of CD4 and CD8 T cells as well as a massive influx of neutrophils. CD8 T
cells present in the lesions of coinfected mice expressed high levels of gzmB and the NK
cell receptor NKG2D. Treatment of mice following infection with LCMV with NKG2D
blocking antibody completely reversed the increase in both disease severity and parasite
burden. Together this study shows that during a coinfection, engagement of NKG2D
can exacerbate disease progression and suggests that targeting of this pathway may be
an option to control immunopathology in Leishmania infected patients.
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4.2 Introduction
Chronic infections with persistent pathogens impact more than a third of the world’s
population. One such infection is caused by the protozoan parasite Leishmania, which
infects 1.2 million people every year and is responsible for the ninth largest disease
burden among individual infectious diseases (Alvar et al., 2012). This neglected tropical
disease has many diverse clinical manifestations from ulcerative skin lesions to
disseminated visceral infection. Approximately 90% of all Leishmania infections are
localized cutaneous forms, but even within cutaneous infections there is a wide
spectrum of disease severity (World Health Organization, 2014). Many factors likely
play a role in this disease spectrum including host and parasite factors, but the specific
causes are unclear.
Experimental mouse models have demonstrated that control of Leishmania infection
requires a robust Type I immune response, characterized by IFN-γ production to activate
infected cells and kill intracellular parasites (Sacks and Noben-Trauth, 2002). The
chronic nature of Leishmania infection and the geographic regions in which it is endemic,
predispose infected patients to a wide variety of coinfections. Many species of intestinal
helminths are prevalent in regions of the world where Leishmania infection occurs and a
study of coinfected individuals revealed that the presence of a helminth resulted in
slower healing and increased Type II immune responses as measured by IgE levels
(O'Neal et al., 2007). Mouse models of coinfection with Schistosoma mansoni and
Leishmania showed a similar skewing towards a Type II immune response with
increased levels of IL-4 production and subsequently increased parasite burden and
delayed lesion resolution (La Flamme et al., 2002). Given this, it follows that a Type I
inducing coinfection may prove to be protective, and in fact, susceptible mouse strains
can be protected when mice are coinfected with Leishmania and Toxoplasma gondii (T.
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gondii) or Listeria monocytogenes (Listeria) (Santiago et al., 1999; Tabbara et al., 2004).
However, lesion size and severity are not always associated with high parasite burden.
The most severe form of cutaneous infection, where mucosal tissue is destroyed, is
associated with relatively low levels of parasite and an overly exuberant immune
response including high levels of pro-inflammatory cytokines (Bacellar et al., 2009).	
  	
  
Here we demonstrate that coinfection of L. major infected mice with a Type I inducing
acute virus, Lymphocytic Choriomeningitis virus (LCMV), not only fails to protect
coinfected mice but rather exacerbates disease severity and increases parasite burden.
Surprisingly, this increased disease is not associated with increased levels of IFN-γ or
IL-17 in the lesion, but rather an influx of gzmB expressing LCMV specific CD8 effector
cells. Both the immunopathology and increase in parasite burden could be blocked by
treatment with anti-NKG2D, an NK cell receptor expressed by the infiltrating CD8 T cells.
This work highlights the fine balance between controlling infection and inducing
immunopathology and demonstrates that this balance can be disrupted by an unrelated
infection.
4.3 Materials and methods
Animals
Female C57BL/6 mice (6 weeks old) were purchased from the National Cancer Institute
(Fredericksburg, MD). Animals were housed in a specific pathogen-free environment
and tested negative for pathogens in routine screening. This study was carried out in
strict accordance with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The protocol was approved by
the Institutional Animal Care and Use Committee, University of Pennsylvania Animal
Welfare Assurance Number A3079-01.
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Parasite, virus, and bacterial infections
L. major parasites (Friedlin) were grown to the stationary phase in Schneider's
Drosophila medium (Gibco) supplemented with 20% heat-inactivated FBS (Gibco) and 2
mM L-glutamine (Sigma) at 26°C (Prickett et al., 2006). Metacyclic promastigotes were
isolated from 4-5 day old stationary cultures by density gradients (Späth and Beverley,
2001). Mice were infected with 2 x 106 metacyclic parasites injected intradermally into
the ear. Lesion development was monitored weekly by taking measurements of ear
thickness with digital calipers (Fisher Scientific). Parasite burden in lesion tissues was
assessed using a limiting dilution assay as previously described (Scott et al., 2004). For
viral infections, mice were infected with 2 x 105 PFU of LCMV Armstrong strain by i.p.
injection.
Flow cytometry
For flow cytometry, cells were isolated from ears, draining lymph nodes, spleens or
peripheral blood. For ears, dermal sheets were separated and incubated in incomplete
IMDM+GlutaMAX (Gibco) containing 0.25 µg/mL of Liberase TL (Roche, Diagnostics
Corp.) and 10 µg/mL DNase I (Sigma-Aldrich) for 90 minutes at 37°C. Ears, draining
lymph nodes, and spleens were mechanically dissociated by smashing through a 40-µm
cell strainer (Falcon) in PBS containing 0.05% BSA and 20 µM EDTA. Splenocytes
were incubated for <1 minute with ACK lysing buffer (Lonza) to lyse red blood cells.
When indicated, cells were incubated at 4 x 106 cells/ml with Brefeldin A (BFA, 3 µg/ml
final concentration) (eBioscience) alone for 5 hours before staining for flow cytometry.
Cells were then incubated with FC block (anti-CD16/32, heat inactivated mouse sera
and Rat IgG) followed by fluorochrome-conjugated antibodies for surface markers CD45,
CD8β, CD4, CD44, CD62L, CD11b, Ly6C, and/or Ly6G (1A8) (all eBioscience) and were
	
  

80	
  

fixed with 2% paraformaldehyde (Electron Microscopy Sciences). Tetramers for GP33
and NP396 conjugated to APC were used where indicated. For intracellular staining,
cells were previously permeabilized with 0.2% of saponin buffer and stained for IFN-γ,
gzmB, TNF-α, and/or IL-17A (eBioscience or Invitrogen). The data were collected using
an LSR Fortessa flow cytometer (BD Bioscience) and analyzed with FlowJo software
(Tree Star).
Histopaque
Peripheral blood was collected into a 4% sodium citrate solution. White blood cells were
isolated by underlaying with Histopaque-1083 (Sigma) and spinning for 20 minutes at
400 x g at room temperature.
Ear Homogenization
Whole ears were placed in ice cold PBS with a protease inhibitor cocktail (Sigma).
Samples were homogenized using the FastPrep-24 (MP Biomedicals) and spun for 5
minutes at 5000 rpm at 4°C in a microcentrifuge. The supernatants were removed and
stored at -80°C until analysis by ELISA as described below.
Leishmanial antigen restimulation and ELISAs
Leishmanial antigen was obtained from stationary-phase promastigotes of L. major by
resuspending parasites at 1 x 109 parasites/ml in PBS and conducting 20 freeze/thaw
cycles. For measurements of antigen-specific cytokine production, the infected skin
draining retroauricular lymph node was removed, mechanically dissociated, and single
cell suspensions were prepared. Cells were resuspended in complete IMDM+GlutaMAX
(Gibco) supplemented with 10% heat inactivated FBS (Gibco), 2 mM L-glutamine
(Sigma), 100 U of penicillin and 100 µg of streptomycin (Sigma) per mL and 0.05 µM of
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β-mercaptoethanol (Sigma). Cells were plated at 4 x 106 cells/mL in 1 ml in 48-well
plates. Cells were incubated at 37°C in 5% CO2 with 20 x 106 L. major parasites/mL.
Supernatants were collected after 72 hours and stored at -20°C until they were assayed
by sandwich ELISA using paired monoclonal antibody to detect IFN-γ, IL-4 or IL-17
(eBioscience). Cytokine concentrations were calculated from standard curves with
detection limit of 0.03 ng/mL for IFN-γ, 0.015 ng/mL for IL-17A and 7 Units/mL of IL-4.
Granzyme B was analyzed by ELISA using a mouse granzyme B Duoset kit (R&D
Systems). IL-1β was analyzed by ELISA using a mouse IL-1β ELISA MAX kit
(Biolegend).
In vivo antibody treatment
NKG2D blocking antibodies (200 µg/dose; Clone HMG2D; BioXCell) were given	
  intraperitoneal 3 days after infection with LCMV and twice weekly for the duration of the
experiment.
Statistics
Results represent means ± SEM. Data were analyzed using Prism 5.0 (GraphPad
Software, San Diego, CA). Statistical significance was determined using unpaired, onetailed Student's t test with p values given as: *p < 0.05; **p < 0.001; and ***p < 0.0001;
ns p > 0.05. Results with a p value ≤0.05 were considered significant.	
  
4.4 Results
Coinfection with LCMV exacerbates lesion formation and increases parasite
burden in L. major infected mice
Previous work has focused on the role of immunological memory on the progression of
disease during L. major infection (Chapter 3). Given that Leishmania is a chronic
infection and lesions can persist for several months, we also wanted to investigate the
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impact of an unrelated infection on the disease course of an established leishmanial
lesion. We infected mice intradermally with L. major and waited 2 weeks for a
measurable lesion to form. A cohort of these mice was then infected with LCMV
Armstrong and the disease progression was followed for 13 weeks with ear
measurements taken weekly (Figure 1A). Mice coinfected with LCMV had a significant
increase in lesion size and delayed healing time following infection with LCMV.
Photographs taken at the peak of lesion formation highlight the increased tissue damage
and ulceration that occurs in the coinfected mice (Figure 1B), but even more striking is
the structural damage and tissue loss that remains even after inflammation and
ulceration have resolved (Figure 1C). Interestingly, the increased pathology is
associated with increased parasite burden in the skin at 3 and 5 weeks post infection
(Figure 1D) and 5 weeks post infection in the DLN (Figure 1E). Analysis of the skin at 7
weeks post infection seems to indicate that the parasite burden is controlled similarly in
the coinfected mice, but later time points are needed to definitively determine this. This
finding is in contrast to that seen with a previous infection with LCMV, in which pathology
was not associated with any concomitant change in parasite control (Chapter 3).
Coinfection with LCMV inhibits Leishmania specific IFN-γ production
Having seen an increase in parasite burden in the coinfected mice, we examined the
anti-leishmanial immune response to determine if it was altered upon infection with
LCMV. Mice were once again infected with L. major and at 2 weeks post infection half of
them were challenged with LCMV. At 3 weeks post L. major infection, cells were
isolated from the DLN of infected mice, including age matched naïve controls and age
and infection matched LCMV alone controls. These lymph node cells were cultured for
72 hours with leishmanial antigen (FTAg) or media alone. At the end of the culture,
supernatants were removed and fresh media with BFA was added for the final 6 hours of
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culture. Cells were then stained and analyzed for IFN-γ production (Figure 2A). As
expected, neither CD4 nor CD8 T cells from naïve or control LCMV infected mice
produced IFN-γ in response to FTAg stimulation (Figure 2A-2D). Mice infected with L.
major alone produced IFN-γ specifically in response to stimulation with FTAg (Figure 2AD). This IFN-γ production was detected intracellularly by cytokine staining as well as
extracellularly in the supernatants by ELISA (Figure 2A and 2D). Interestingly, cells
taken from coinfected mice had a defect in FTAg induced IFN-γ production (Figure 2A2C). This was reflected by a decrease in the percentage of CD4 and CD8 T cells
staining for IFN-γ intracellularly as well as a decrease in the total accumulated IFN-γ
found in the supernatants (Figure 2A and 2D).
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Figure 2 Coinfection with LCMV inhibits leishmania specific IFN-γ production early.
Mice were infected with L. major or left uninfected for 2 weeks. Some mice from each group
were then infected with LCMV. Cells from the DLN of infected mice or pooled LNs from
naïve mice were stimulated in vitro with media alone or leishmanial antigen (FTAg) 1 week
(A-D) or 3 weeks (E-H) after LCMV infection for 72 hours. After 72 hours, supernatants from
the cultures were removed and analyzed by ELISA (D and H). BFA and fresh media were
added to the cells for 6 hours, after which they were stained for IFN-γ (A and E). The
percentage of CD44hi CD8 (B and F) and CD4 (C and G) T cells making IFN-γ was
calculated. Data are representative of two independent experiments (n=3-5 mice per
group). Error bars represent SEM.
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There are several possible explanations for the IFN-γ defect that was observed. It is
possible that the decrease in Leishmania responsive cells in the DLN is due to the
significant expansion of LCMV specific cells at this time point (Masopust et al., 2007)
leading to a decreased number of L. major specific cells in the same number of total LN
cells. The defect in IFN-γ production could also be the result of a temporary anergic
state seen in T cells following acute infection with LCMV, during which cells are
refractory to additional stimulation (Brojorge.K and Volkert, 1974; Butz and Southern,
1994; Mims and Wainwrig, 1968; Saron et al., 1990). High levels of Type I IFNs can
also induce this unresponsive state (Marshall et al., 2011; Redford et al., 2014; Wilson et
al., 2013). Regardless of the mechanism involved, given the critical role that IFN-γ plays
in controlling parasite burden, an impairment of Leishmania specific IFN-γ production is
consistent with the increased parasite burden observed in the skin and DLN early on
during the coinfection (Figure 1C and 1D).
If the loss of functionality observed above was dependent on LCMV infection induced
unresponsiveness, we would predict that it would be transient, and should
responsiveness to Leishmania antigen should return following resolution of LCMV
associated inflammation. Therefore, similar analysis of DLN cells from mice 5 weeks
post L. major infection. At this time point, IFN-γ production by both CD4 and CD8 T cells
in coinfected mice has recovered to levels similar to those seen in mice infected with L.
major alone (Figure 2E-2H). Also contrary to what was seen at 3 weeks post L. major
infection, cells from coinfected DLNs 5 weeks post L. major infection produced
comparable levels of IFN-γ regardless of whether FTAg was added to the cultures or not
(Figure 2E). This is observed in both the flow analysis of intracellular IFN-γ and the
ELISA for IFN-γ protein in the supernatants (Figure 2E and 2H). The recovery of IFN-γ
production is also consistent with the finding that parasite burdens in the coinfected mice
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are controlled at later time points similarly to L. major singly infected animals (Figure
1C). The increased background IFN-γ production seen in unstimulated DLN cells from
coinfected mice may be due to the increased parasite load present in this tissue at this
time point, stimulating IFN-γ production even in absence of additional exogenous
leishmanial FTAg (Figure 1D). Future work will determine if this is a general IFN-γ
overproduction that occurs at this time post LCMV infection or an attribute that is specific
in our coinfected mice.
Coinfection does not alter clearance of LCMV or the expansion of LCMV specific
CD8 T cells
Given the impact of LCMV infection on the control of L. major, we wanted to investigate
whether coinfection altered the ability to respond to or control LCMV. Serum, spleen,
and kidney samples were taken from mice infected with LCMV alone or coinfected mice
at 3, 7 and 10 days post LCMV infection. These tissues were analyzed for LCMV viral
titers and virus was detectable at similar levels between the two groups in the serum,
kidney, and spleen at day 3 post LCMV infection (Figure 3A). The virus was not
detectable in any of the tissues from either group by day 7 or 10 post LCMV infection,
indicating that the virus is controlled similarly regardless of whether an L. major infection
is present.
Another measure of the LCMV immune response is to track expansion of the CD8 T
cells. Analysis of the activated population of CD8 T cells in the spleen at 7 days post
infection as measured by their expression of CD44 and CD62L revealed similar
activation profiles in LCMV infected mice irrespective of L. major infection (Figure 3B).
This included significant expansion of activated CD8 T cells, with the CD44hi population
accounting for almost 100% of CD8 T cells present in the spleen (Figure 3B). This is in
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Figure 3 Coinfection of LCMV and L. major does not alter the magnitude of the LCMV
immune response or the clearance of virus. Mice were infected with L. major or left
uninfected for 2 weeks. Some mice from each group were then infected with LCMV. Three
days after infection with LCMV, serum, kidney, and spleen samples were taken to assess
viral titers by plaque assay (A). One week post infection with LCMV, spleens were harvested
and stained with activation markers CD44 and CD62L (B). Quantification of each cell
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stained with LCMV tetramers, GP33 (A) and NP396 (C). Tetramer plots were pregated on
live/CD8+/CD44hi cells. Representative plots (C and D) and quantification (D and F) are
shown. Data is representative of a single experiment (n=3-4 mice per group). Error bars
represent SEM. NS = not significant
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contrast to the relatively low proportion of activated CD8 T cells in mice infected with L.
major alone. Staining with tetramers for two of the immunodominant LCMV epitopes
also showed similar frequencies of GP33+ and NP396+ CD8 T cells in LCMV alone and
coinfected mice (Figure 3C-3F). Taken together, these data demonstrate that clearance
of the virus and the magnitude of the immune response at the peak are unaffected by L.
major infection.
Coinfection significantly alters the cellular infiltration into L. major infected skin
Coinfection with LCMV after the establishment of a L. major infection induced
significantly larger lesions characterized by increased ulceration and tissue loss. Given
this pathology, we next wanted to examine the composition of cells present in these
lesions. The peak of lesion formation was 5 weeks post L. major infection and 3 weeks
post LCMV infection. At this time, we digested the infected skin and analyzed the
cellular infiltration by flow cytometry. As predicted based on our previous work with
LCMV effector cell transfers and infection of LCMV immune mice (Chapters 2 and 3),
there was a significant increase in the frequency of CD8 T cells present in the lesions of
coinfected mice (Figure 4A-4B). In our previous work with LCMV immune mice, despite
an increase in CD8 T cells, there was no change in CD4 T cell infiltration into the lesions
(Chapter 3). Additionally, while the number of monocytes and neutrophils also increased
in LCMV immune L. major infected mice, the relative proportion remained similar. In
contrast, in lesions from coinfected mice there was an increase in the infiltration of CD4
T cells and neutrophils but a loss in infiltrating inflammatory monocytes (Figure 4A-4B).
The pus and ulcer formation observed in coinfected mice is consistent with excessive
neutrophil recruitment and activation (Boaventura et al., 2010; Segel et al., 2011).
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Figure 4 Coinfection with LCMV results in a significant increase in T cells and gzmB in
the infected skin. Mice were infected with L. major or left uninfected for 2 weeks. Some
mice from each group were then infected with LCMV. At the peak of lesion formation, 5
weeks after the initial infection with L. major, infected skin was harvested, digested, and
stained with antibodies for T cells and myeloid cells (A). T cells were pregated on live,
CD45+, CD11b- cells before the gates shown for CD4 and CD8 T cells. Myeloid cells were
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5 hours prior to intracellular staining for GzmB, IFN-γ, and IL-17 (C). Representative plots (C)
and cell numbers for Gzm+ cells (D) are shown for CD4 and CD8 T cells. Whole ear tissue
was homogenized and supernatants were anlzyed for GzmB, IFN-γ, and IL-17 by ELISA
(E). Flow data are representative of two independent experiments (n=4-5 mice per group)
and ear supernatant data is representative of a single experiment (n=4 mice per group).
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We next wanted to determine if the functionality of the T cells present in the lesions
could explain the increased pathology or recruitment of neutrophils. We isolated cells
from the infected skin 5 weeks post L. major infection and incubated them with BFA but
no additional stimulus in an effort to capture their functionality directly ex vivo.
Consistent with previous work examining cytokine production by CD8 T cells from the
infected skin there was little to no detectable IFN-γ or IL-17 production in either group
(Figure 4C). In contrast, a significant proportion of CD8 T cells were expressing gzmB,
with a higher percentage of CD8 T cells from coinfected mice expressing gzmB (Figure
4C). Similarly, while some IFN-γ and IL-17 production was detectable by CD4 T cells,
there was no difference seen between the two groups (Figure 4C). When numbers of
gzmB expressing CD8 T cells were calculated, there were overwhelmingly more gzmB
expressing CD8 T cells in the coinfected mice than those infected with L. major alone
(Figure 4D). Importantly, when infected skin was homogenized and the total proteins
present were analyzed there was no difference in the amount of IFN-γ or IL-17 levels
between the two groups, but coinfected mice had four times more gzmB than mice that
had been infected with L. major alone (Figure 4E). Taken together these results indicate
that IL-17 is not likely to be the factor responsible for increased neutrophil recruitment to
the coinfected mice. Additionally, the increase in parasite burden does not appear to be
due to a lack of IFN-γ production within the infected skin. The most abundant protein
found in the skin was gzmB, potentially implicating cytotoxicity in the observed
recruitment of neutrophils and resulting immunopathology.
We have shown previously that LCMV specific effector cells migrate into leishmanial
lesions (Chapter 2). Additionally, it has been demonstrated that large numbers of LCMV
specific CD8 T cells infiltrate a Mycobacterium bovis induced granuloma following an
acute LCMV infection (Hogan et al., 2007). Based on these observations, our current
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hypothesis is that LCMV infection activates and expands a large population of CD8 T
cells that are recruited into the site of active inflammation in the leishmanial lesion.
Future studies will be directed at testing this hypothesis.
Coinfection with LCMV results in high expression of NKG2D by CD8 T cells
Previous work has demonstrated that LCMV specific memory cells maintain expression
of the NK cell receptor NKG2D (Chapter 3). This receptor has been demonstrated to act
not only as a costimulatory receptor on CD8 T cells, but can also mediate direct, TCRindependent cytotoxicity (Groh et al., 2002; Jamieson et al., 2002; Meresse et al., 2004;
Tietze et al., 2012; Verneris et al., 2004). We compared the expression of this receptor
on CD44hi CD8 T cells in the blood, DLN, and infected skin in mice infected with L.
major alone or coinfected with LCMV and L. major (Figure 5A). CD8 T cells from
coinfected mice had significantly higher expression of NKG2D in all three tissues (Figure
5B).
Monocytes in L. major infected skin express higher levels of Rae1-γ than
neutrophils
We have previously shown that one of the ligands for NKG2D, Rae1-γ, is highly
expressed in the skin following L. major infection (Chapter 3). We wanted to further
demonstrate the relative expression of this ligand by different cells types in the lesion.
Examining the expression of Rae1-γ by monocytes and neutrophils we found that both
cell types expressed Rae1-γ. However, there appeared to be two levels of expression of
this ligand by monocytes and neutrophils, a population of high expressers and a
population of low expressers (Figure 5C). In both mice infected with L. major alone and
coinfected mice, monocytes expressed higher levels of Rae1-γ than neutrophils, with the
majority of monocytes falling in the high expressing population (Figure 5D). It is
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currently unknown what distinguishes these two populations of high and low expression
of Rae1-γ in monocytes and neutrophils. We might predict that cells infected with
parasite will express higher levels, and use of fluorescent parasites will allow us to
determine if this is the case.
Immunopathology in coinfected mice is mediated by engagement of NKG2D
Coinfection of L. major infected mice with LCMV resulted in the infiltration of NKG2D and
gzmB expressing CD8 T cells. Knowing that NKG2D expressing memory CD8 T cells
mediated increased immunopathology through this receptor (Chapter 3), we wanted to
test whether the observed immunopathology during coinfection was also dependent on
engagement of this receptor. We followed the same infection time line as before, adding
treatment with NKG2D blocking antibodies biweekly beginning 3 days after LCMV
infection. Treatment of coinfected mice with anti-NKG2D completely blocked the
increase in ear thickness (Figure 5E). The lesions in these mice were visibly smaller
and had no ulceration (Figure 5F). Strikingly, this treatment not only blocked the
immunopathology, but it also restored control of parasite burden (Figure 5G).
Coinfected mice treated with anti-NKG2D had no change in the recruitment of CD4 T cell
to the lesion (Figure 5H and 5I). Interestingly, while there were still significantly more
CD8 T cells in anti-NKG2D treated coinfected mice than mice that had been infected
with L. major alone, there were approximately half as many as in control coinfected mice
(Figure 5H and 5I). Anti-NKG2D treatment also led to a partial restoration in monocyte
infiltration and completely blocked the excessive infiltration of neutrophils in the
coinfected mice (Figure 5H and 5I). Currently, the data demonstrates that the NKG2D
pathway is responsible for the exacerbated lesion formation and increased parasite
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burden, and that blockade of this pathway completely blocks the pathology and restores
parasite control.
4.5 Discussion
This study explores the impact of LCMV infection on the progression of an established
leishmanial lesion. Unexpectedly, this coinfection results in not only significantly
exacerbated disease severity but also transiently impaired parasite control. Given the
chronic nature of Leishmania infection, understanding the impact of additional infections
during the course of active disease has critical applications for human health. Much
study in this area has focused on the impact of coinfections that would be predicted to
induce an alternate type II immune response, like helminths and other intestinal
parasites. A mouse model of Schistosoma mansoni and L. major coinfection resulted in
a delayed IFN-γ and increased IL-4 response to L. major, ultimately leading to increased
parasite burden and delayed healing (La Flamme et al., 2002). A clinical study of
patients in Brazil found that patients who were coinfected with an intestinal helminth at
the time of Leishmania diagnosis took longer to heal and exhibited increase type II
immune responses as measured by serum IgE levels (O'Neal et al., 2007). The
opposite effect has also been shown using strong type I inducing infections like T. gondii
and Listeria coinfections with Leishmania to protect otherwise susceptible strains of mice
(Santiago et al., 1999; Tabbara et al., 2004). Here we see not only increased pathology,
but also an increase in the peak parasite burden of coinfected mice. Rather than an
increased IFN-γ response in the coinfected mice that we would have predicted based on
previous work, there was a defect in Leishmania specific IFN-γ production observed at 3
weeks post L. major (Figure 2A-2D). LCMV induces an extensive T cell response that
can account for at least 80% and possibly as much at 95% of the CD8 T cell pool at its
peak (Figure 3B and Masopust et al., 2007; Murali-Krishna et al., 1998). This expansion
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also leads to a shift in the CD4:CD8 T cell ratio in the DLN and may decrease the
number of leishmania responsive cells present there enough to result in the IFN-γ
production defect that we see. Following this massive expansion, there can be also be a
period of time during which cells from these mice are refractory to further stimulation,
possible resulting in the lack of anti-leishmanial IFN-γ production (Butz and Southern,
1994; Saron et al., 1990). Other evidence indicates that the high levels of Type I IFNs
present during an acute viral infection like LCMV can also result in a decreased
responsiveness by T cells following infection (Marshall et al., 2011; Redford et al., 2014;
Wilson et al., 2013). This blunted anti-leishmanial immune response was seen in both
CD4 and CD8 T cells and may be partially responsible for the increased parasite burden
seen at this time point.
This data also highlights the fine balance between a potentially protective increase in the
immune response and the generation of immunopathology. There is increasing
evidence that CD8 T cells, despite their ability to produce IFN-γ, can also act to promote
tissue damage (Chapter 2 and 3 and Novais et al., 2013; Santos et al., 2013). Patient
lesions have been shown to contain large numbers of CD8 T cells, many of which
appear to be specific for pathogens other than Leishmania (Da-Cruz et al., 2010). This
observation was unexpected, given that many of the CD8 observed in both mouse and
patient lesions expressed gzmB, an effector protein usually associated with antigen
specific responses (Dantas et al., 2013; Faria et al., 2009). These studies identify
NKG2D as a potential mechanism by which gzmB expressing non-antigen specific CD8
T cells could be inducing pathology and potentially parasite spread. In vitro experiments
indicate that killing of a Leishmania infected cell by CD8 T cells does not kill the parasite,
but instead releases infectious parasites to potentially infect surrounding cells (Smith et
al., 1991). As a result, excessive lysis of infected cells within the lesion by LCMV
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derived effector CD8 T cells through NKG2D could not only explain the extensive tissue
damage, but also the increase in parasite burden at the peak of infection.
Treatment with antibodies that blocked NKG2D engagement resulted in decreased
recruitment of CD8 T cells to the infected skin. There are several possible reasons that
NKG2D treatment might have this effect. NKG2D engagement with its ligand has been
shown to be sufficient for recruitment and retention of CD8 T cells into the pancreas
(Markiewicz et al., 2012). Blockade of this interaction may lead to a decreased retention
of effector CD8 T cells in lesion. NKG2D can also act as a costimulatory molecule and it
is not known what role this pathway plays in during the priming of CD8 T cells during
LCMV infection. A recent paper even suggests that blockade of NKG2D during acute
LCMV infection actually enhances the CD8 T cell response (Lang et al., 2012). At 5
weeks post L. major infection, the percentage of both total and activated CD8 T cells in
the blood of coinfected or anti-NKG2D treated coinfected mice was the same,
suggesting a comparable immune response in both groups (data not shown).
Additionally, the DLNs of these mice were the same size and cellularity (data not
shown). The impact of NKG2D blockade on the LCMV specific immune response and
viral control will be examined in future work.
At 5 weeks post L. major infection there was a notable loss of the monocyte population
in coinfected mice that was not observed when LCMV immune mice were infected with
L. major (Figure 4A and Chapter 3). However, at 3 weeks and 7 weeks post infection,
monocyte populations return to comparable numbers as mice infected with L. major
alone (data not shown). Monocytes in the infected skin express high levels of the
NKG2D ligand Rae1-γ whereas neutrophils express much lower levels of this protein
(Figure 5C and 5D). A possible explanation for the loss at the peak of infection is
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targeted killing of the highly expressing Rae1-γ monocyte population by activated CD8
effector cells. Neutrophils have been shown to effectively take up parasites, but are less
efficient at killing them than monocytes, instead providing a potential ‘home’ for parasite
replication, consistent with the increased parasite burden observed in coinfected mice
(Laskay et al., 2003). Alternatively, LCMV effector CD8 T cells may produce different
chemokines or cytokines than LCMV memory CD8 T cells upon entering the
inflammatory environment of the leishmanial lesion. Memory CD8 T cells produce CCL3
and/or CCL4 in response to secondary infection with LCMV or Listeria (Narni-Mancinelli
et al., 2007; Schenkel et al., 2013). However, no work has been done to determine what
chemokines are produced by CD8 T cells upon entry into a non-antigenic inflamed
environment or whether effector and memory CD8 T cells will respond differently to this
environment. Production of excessive neutrophil specific chemokine like CCL4 could
result in the preferential recruitment of these cells to the infected skin (Kobayashi, 2008).
Understanding the regulation of CD8 T cell effector functions like chemokine and
cytokine production in multi-infection settings and complex inflammatory environments is
an important question to address as we seek to better understand immune responses in
patients.
Chronic and persistent infections represent a significant disease burden worldwide.
Leishmania infection alone impacts people in 98 countries, with 1-2 million newly
infected individuals each year (Alvar et al., 2012). In addition, Leishmania is endemic to
areas of the world where intestinal helminth and HIV infections are also highly prevalent.
The incidence of Leishmania/HIV coinfection is growing rapidly and is associated with an
increased rate of leishmanial recurrence and a decreased responsiveness to therapy
(Couppie et al., 2004). A study of cutaneous Leishmania patients in Brazil at the time of
diagnosis revealed that 88.3% of the patients were coinfected with at least 1 species of
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helminth, with 73% of the patients harboring multiple species (O'Neal et al., 2007). This
cohort was followed and found that coinfected individuals took longer to heal their
lesions. Our work demonstrates that the coinfection does not have to be with another
chronic pathogen; rather leishmanial disease progression can be affected by an acute
viral infection. Overall, this work highlights the need for a more systemic understanding
of bystander immune responses that are occurring during chronic infections in order to
improve therapies and create more targeted and effective treatments.
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Chapter 5 Discussion
The focus of this work has been on understanding the role of CD8 T cells, particularly
during heterologous infections, on the disease course of L. major infection. The findings
have demonstrated that CD8 T cells in the skin appear to have a cytotoxic phenotype,
which is consistent with other work from our lab and observations of CD8 T cells in
human lesions (Dantas et al., 2013; Faria et al., 2009; Novais et al., 2013; Santos et al.,
2013). Using unrelated, acute infections to generate a large population of memory CD8
T cells, we demonstrated that bystander memory cells can be recruited into the lesion
and exacerbate the course of disease (Figure 1). This immunopathological property was
not limited to memory cells, as coinfection of mice with LCMV after the formation of a
lesion also exacerbated disease. In both cases, the pathology was dependent on the
engagement of NKG2D with its ligands, resulting in cell death, tissue damage, and the
recruitment of inflammatory cells that perpetuated the cycle of inflammation (Figure 1).
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Overall, these data raise several important questions. Here we will discuss the
implications for this work as we think about the use of a mouse model to study infectious
diseases, the innate-like functioning of bystander memory cells and its impact on future
infections, the skin as a specific immunologic niche, and how these findings might
impact the treatment of leishmaniasis.
Innate functions of CD8 T cells: bystander activation and its implications for
human health
The role of CD8 T cells in both primary and secondary adaptive immune responses has
been well characterized. Intricate positive and negative selection ensures that these T
cells are able to respond only to appropriate antigens and complex regulatory networks
exist to ensure non-responsiveness to self (Starr et al., 2003). The formation of long
lasting, pathogen specific immunologic memory is one of the hallmarks of adaptive
immunity. However, more recently the field has begun to appreciate an innate-like
functioning of CD8 T cells that is independent of antigen specific signals. While naïve T
cells require signals through their TCR, previously activated effector or memory cells can
upregulate substantial effector functions in response to cytokine signals in their
environment. This is referred to as bystander activation and has been historically
somewhat controversial. Initially, the massive expansion of T cells following viral
infection was thought to be due to bystander activation, but the advent of tetramer
technology has demonstrated that antigen specific responses can be much larger than
was previously thought (Masopust et al., 2007; Murali-Krishna et al., 1998). Use of
transgenic cells has further demonstrated the capacity for antigen specific proliferation,
but has also made it clear that memory cells can be activated independent of antigen
specificity by a subsequent, unrelated pathogen (Berg et al., 2003). This phenomenon
has been termed heterologous immunity and has been demonstrated between different
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strains of closely related viruses, different members of the same virus group, and also
among completely unrelated pathogens like parasites, bacteria and viruses (Reviewed in
Sharma and Thomas, 2014). In many situations heterologous immunity can result in
increased protection from subsequent infections (Berg et al., 2003; Mathurin et al., 2009;
Soudja et al., 2012), while in other cases, stimulation of heterologous immunity results in
increased immunopathology or the induction of autoimmune diseases (Chen et al., 2001;
Meresse et al., 2004). Understanding the balance between protective and pathologic
effector functions of bystander cells has important implications for human health.
The first effector function of bystander CD8 T cells to be implicated in the induction of
both protection and immunopathology is cytokine production. When considering the
innate functioning of bystander cells, production of cytokines as a means of influencing
future infections is logical. We know that memory cells can rapidly produce cytokines in
response to inflammatory signals (Freeman et al., 2012). Cytokines can influence the
cells around them, activating or skewing the type of immune response being mounted,
irrespective of antigen specificity. In some settings, cytokines can result in control of
pathogens, while in others, cytokines can cause tissue damage and inflammation
(Angulo and Fresno, 2002; Wack et al., 2011). This can vary depending on the specific
cytokine, the pathogen involved, the local concentration of cytokine, and the tissue
where the response is taking place. While excessive cytokine production by bystander
cells could certainly be an issue, many innate cells produce cytokines in a similarly ‘nonspecific’ way without catastrophic consequences. However, there is increasing evidence
that bystander CD8 T cells are not just functioning as cytokine producers, but can also
have cytolytic activity. The notion that a bystander CD8 T cell can not only secrete
cytokines, but can kill independently of its TCR is much more teleologically alarming.
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Historically, when bystander killing was observed, it was explained as a byproduct of
cross-reactivity or potentially the expression of two TCRs with differing specificities on
the same cell (Nahill and Welsh, 1993; Selin et al., 2006; Sheil et al., 1987). But the use
of tetramers and transgenic technology has allowed the convincing demonstration of
bona fide bystander killing that is independent of antigen specificity (Chu et al., 2013;
Meresse et al., 2004). One study demonstrated that Sendai virus specific bystander
cells expressed high levels of gzmB in the lung following Influenza infection and led to
increased control of Influenza virus early during the infection (Kohlmeier et al., 2010).
Surprisingly, they went on to show that these cells lysed Sendai pulsed target cells,
despite the complete absence of Sendai virus from the lungs at the time of Influenza
infection, but failed to examine whether they could lyse Influenza pulsed target cells.
They maintained that the increased cytotoxicity was antigen specific but never explained
how Sendai specific cytotoxic potential was controlling Influenza infection. More recent
work, including the work shown here, has provided a much more satisfying explanation
for how bystander cells expressing cytotoxic proteins could be influencing unrelated
infections, through the engagement of NKG2D.
Memory CD8 T cells have been shown to express the NK cell receptor NKG2D, and
binding of this receptor can lead to direct, TCR-independent cytotoxicity. Our work
highlights a specific instance in which bystander CD8 T cells induce cytolysis through
engagement of NKG2D. Blockade of this interaction completely blocked the
immunopathology caused by CD8 T cells, but targeting of this pathway for potential
therapies will require a much greater understanding of how and when signaling through
this pathway occurs in CD8 T cells. Self-reactive NKG2D expressing CD8 T cells have
also been shown to play a role during several autoimmune diseases, including Celiac
disease and diabetes, through MHC unrestricted cytotoxicity (Meresse et al., 2004;
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Ogasawara et al., 2004). The demonstration of NK-cell-like killing by CD8 T cells,
particularly during autoimmune disease, raises some important questions about how this
process is regulated. NK cells express a complex network of inhibitory and activating
receptors that constantly signal, the sum of which determines whether the NK cell will
‘act’ or not (Pegram et al., 2011). While some work has been done to examine the
expression of these NK cell receptors on CD8 T cells, much less is known about how
they impact the functionality of CD8 T cells and how they interact with each other to
provide positive and negative feedback. Conventionally, NKG2D has been reported to
act as a costimulatory molecule during the priming of CD8 T cells, but even this finding
seems to be very context and infection dependent. It will be important to understand if
signaling through these receptors is different not only during various infections, but also
how signaling varies in naïve versus effector versus memory T cells, as we already know
that downstream TCR signaling is distinct depending on the activation state of the cell
(Kersh et al., 2003). In all, our understanding of NK cell receptor expression, interaction,
regulation, and function on CD8 T cells is lacking and represents an important potential
component of overall CD8 T cell function.
Some of the first evidence that CD8 T cells expressed NKG2D and could kill nonspecifically through this receptor was in the setting of cancer immunotherapy. Treatment
of T cells with high doses of IL-2 induces potent cytotoxic effector cells that express both
gzmB and NKG2D (Tietze et al., 2012; Verneris et al., 2004). We also saw the induction
of gzmB by CD8 T cells in response to IL-2 in vitro, although its effect on NKG2D
expression was not examined in our experiments (Chapter 1, Figure 5). Significant antitumor cytotoxicity in response to IL-2 treatment was seen even when using transgenic
cells against non-antigen expressing tumors and could be blocked by treatment with
anti-NKG2D. This data demonstrates a potential opportunity to augment anti-tumor
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responses by targeting this pathway more specifically. As chimeric antigen receptors
become more complex with the addition of costimulatory domains, NKG2D stands out as
a prospect. This data also suggests that immunotherapies utilizing high dose IL-2 or the
expansion ex vivo of T cells in IL-2 or IL-15 could result in unwanted bystander
activation, killing, and potentially the induction of autoimmunity.
Overall, innate functioning of both antigen specific and bystander memory cells occurs in
vivo. Our current understanding of how these functions are induced and regulated is
lacking. Expression of innate receptors like NKG2D represents an exciting new avenue
into understanding the complexities of T cell responses that occur in patients. The data
suggest that finding ways to both inhibit and augment signaling through this pathway
warrants further, careful study.
Studying T cells in a mouse
The textbook description of T cell activation mandates engagement of the TCR to
‘license’ a T cell to respond in an antigen specific manner. Following an initial expansion
and contraction phase, a stable memory population of T cells is formed and activated
upon future exposure to the initiating pathogen. Unfortunately, this is where our
understanding of T cell responses, gleaned mostly from mouse studies, begins to break
down. We have long appreciated that effector and memory T cells can respond to their
environment both in conjunction with and independently of TCR signals, but the true
breadth of this response in vivo is only partially understood. The complexity of the
different microenvironments in which T cells must respond include duration, receptor
expression, nutrient and oxygen availability, the structure of the reticular network, and
location- both across different tissues and at different sites within a tissue- to name a
few. Add to this the spectrum of activation states (naïve versus effector versus memory)
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of the T cells involved and understanding or predicting how a T cell population will
respond to a given infection becomes difficult, if not impossible. This unmanageable
complexity is what makes the specific pathogen free (SPF), genetically identical mouse
model so attractive. However, this decrease in complexity comes at a cost, and as the
field moves forward it may ultimately limit the possible applications for understanding
human health and disease.
Our studies have identified and attempted to address at least one of the issues with the
SPF mouse model: using immunologically ‘naïve’ mice to study the immune response to
pathogens. While it is no surprise that there does not exist an immunologically naïve
human, we base our understanding of immune responses on data collected almost
exclusively from animals in this naïve state. It is becoming increasingly clear that
previous immunological exposure has a significant impact on the character and quality of
the immune response that is mounted. The studies described here outline the
consequences of two different scenarios, both of which can be expected to occur during
the natural course of infection with Leishmania. The first is an example of the impact of
immunological history on future immune responses, where a previously cleared,
unrelated acute viral or bacterial infection altered the magnitude and quality of the
immune response to Leishmania. Here parasite burden was not impacted, but
significant immunopathology was induced. This result is reminiscent of the clinical
spectrum of disease that is seen in patients and allows one to speculate that individual
immunologic patient histories may be part of the story when predicting disease severity
and response to treatment. The second scenario is a direct coinfection, where mice are
infected with a virus while a lesion is present in the skin. Again we see dramatically
altered immunopathology and a surprising impact on both parasite burdens and the antileishmanial immune response.
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Previous infection induces several important changes to the immune system that can
impact future responses. One of these changes that is particularly important when
studying immune responses in the skin, is the seeding of immune cells into nonlymphoid tissues. Following priming of an adaptive immune response in the spleen,
cells acquire promiscuous homing capabilities and are dispersed throughout the body,
presumably to ensure complete clearance of the pathogen (Liu et al., 2006; Masopust et
al., 2004; Masopust et al., 2010; Stevceva et al., 2002). There is a growing appreciation
that these cells become resident within peripheral tissues and can remain there
indefinitely (Ariotti et al., 2012; Gebhardt et al., 2009; Mackay et al., 2013). As a result,
over time human peripheral tissues acquire resident memory T cells specific for
numerous pathogens. The skin is a particularly striking example when comparing the
SPF mouse model to data from humans. Quantification of T cells in human skin
samples revealed that nearly twice as many cells are present within the skin at steady
state as are present in the circulation (Clark et al., 2006). This is in stark contrast to the
number of T cells observed in the ear skin from SPF mice, where there is a small
population of CD4 T cells and CD8 T cells are virtually absent (Chapter 2, Figure 1).
Recent work has demonstrated the dramatic difference that having CD8 T cells present
within the female reproductive tract can have on the initiation speed and magnitude of a
protective immune response to a challenge at this site (Schenkel et al., 2013).
Alternatively, our work has highlighted the detrimental role these cells can play in
subsequent immune response through the induction of immunopathology. While the
details are likely case specific, the conclusion remains the same: previous exposure to
pathogens changes tissues and impacts future immune responses. Despite the
convenience of the mouse model, this is a complication that cannot be ignored if we are
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to further our understanding of the immune response as a system that is more than a
sum of its individual parts.
Another problematic aspect of studying immune response in the SPF mouse model is
the use of genetically identical, inbred mouse strains. Leishmaniasis provides a perfect
opportunity to make this point, as different genetic strains exhibit wildly different abilities
to control parasite replication. Often the strain differences seen during Leishmania
infection are over simplified into the observation that protected strains (BL6) having an
inherently more TH1 biased response, whereas as susceptible strains (BALB/c) are
skewed towards a TH2 response. While this observation has provided us with important
information about the requirements to control Leishmania infection, it complicates our
translation of these studies to patients. It is easy to fall into the trap of thinking of
patients as falling somewhere on the spectrum between a BL6 and BALB/c mouse,
when in reality we may have artificially chosen two genetic representatives whose
homologues rarely, if ever, appear in an actual human population. It has been shown
that MHC diversity significantly impacts an individual’s ability to control certain
pathogens, and there are many other allelic differences that are more difficult to track at
a population level that likely have a significant impact on the immune response as well
(Penn et al., 2002). Assessing genetic variation in human patients as it relates to
disease severity is increasingly common and represents an exciting and informative step
in the study of human disease. Again, the usefulness of the mouse model is undeniable,
but ultimately it is crucial to keep in mind the limitations when conducting translational
research.
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Leishmaniasis: CD8 T cells, therapy and the skin
Skin infections have several unique characteristics that make them both interesting and
challenging. As a barrier surface, the skin represents a unique niche for commensals,
pathogens, and immune cells. Like the gut, a delicate balance of regulation and
activation must be achieved to maintain homeostasis while still protecting against
pathogens. The microbiome and regulatory components of the skin immune system
cannot be ignored when considering immune responses occurring at this site.
Cutaneous commensal bacteria drive both protective IFN-γ production and pathologic
lesion formation during L. major infection (Naik et al., 2012). It is unclear what role
commensal bacteria may play in NKG2D mediated killing by CD8 T cells, but altering the
gut commensal flora had a significant impact on the expression of NKG2D ligands
(Hansen et al., 2013). In this study, treatment with vancomycin led to decreased ligand
expression by the intestinal epithelium, whereas treatment with ampicillin led to a
dramatic increase in the expression of NKG2D ligands. This opens the possibility that
there may also be a link between commensals and the expression of NKG2D ligands in
the skin and that expression could be altered by topical antibiotic treatment during
Leishmania infection.
Regulatory T cells are present at a particularly high proportion within the skin and are
required for the maintenance of homeostasis at this site (Dudda et al., 2008). They also
play an important role in regulating the persistence of Leishmania parasite in the skin
after overt disease has healed (Belkaid et al., 2002). Neutralization of IL-10 led to sterile
cure of parasite but a concomitant loss of immunity to reinfection, emphasizing the
importance of regulation of the immune response during Leishmania infection. Blockade
of IL-10 receptor during L. major infection also resulted in increased IFN-γ production by
CD8 T cells in skin, which may contribute to the sterile cure observed (unpublished
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data). This suggests that regulation of CD8 function is occurring in the skin, potentially
by IL-10, that inhibits IFN-γ production by CD8 T cells and may play a role in causing
them to adopt a cytotoxic phenotype. Here we have shown that IL-15 is in part
responsible for the expression of gzmB by CD8 T cells in the skin. It is likely that the
cytotoxic phenotype observed by both antigen specific and non-specific cells in the skin
is the cumulative result of inflammatory signals that enforce the expression of gzmB and
inhibitory signals, like IL-10, that repress cytokine production. Moving forward, it will be
important to establish a better understanding of the specific inflammatory and regulatory
signals present in the skin during Leishmania infection, with the hopes of being able to
tip the balance in favor of protection rather pathology.
When considering new therapies to target these pathologic CD8 T cells, we have
identified NKG2D as a potential new pathway. While we treated the mice systemically
with NKG2D blocking antibodies, another recent study employed a localized, intranasal
treatment during influenza infection and was able to block CD8 cytotoxicity (Sckisel et
al., 2014). The cutaneous nature of Leishmania infection raises the possibility of a
localized treatment with blocking reagents that could significantly minimize off target
effects. However, blocking antibody is not the only option for negatively regulating this
pathway. Several groups have discovered soluble forms of NKG2D ligands in the sera
of cancer patients (Champsaur and Lanier, 2010). Presence of these ligands in the sera
of melanoma patients was a strong indicator of a poor prognosis (Paschen et al., 2009).
Incubation of CD8 T cells with this sera or purified soluble ligands significantly
decreased the expression levels of NKG2D on these cells and impaired their antitumor
activity (Groh et al., 2002). While in the context of cancer, the repressive effects of
soluble NKG2D ligands are detrimental, in the setting of Leishmania infection it
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represents a potential therapeutic agent to minimize NKG2D/CD8 mediated
immunopathology.
Overall, this work demonstrates the pathological function of bystander CD8 T cells
during Leishmania infection and ultimately the impact that previous infections can have
on disease severity. It suggests that the spectrum of disease seen in patients may be
due in part to their individual immunological history. While we cannot, and would not
want, to eliminate the memory cells that are inducing pathology, here we show a very
specific way to inhibit their activity in the lesions. NKG2D blockade represents an
immune modulator that allows for the repression of pathologic cytotoxicity without
inhibition of protective immune responses. Treatment with antibodies against NKG2D
was effective in mice, but soluble NKG2D ligands may be an even simpler solution in
patients that has broader applications for not only leishmaniasis but also many
autoimmune diseases.
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